Novartis Media Releases Latest Novartis Media Releases in English en http://www.novartis.com Copyright (c)2005 Novartis International AG http://blogs.law.harvard.edu/tech/rss Hugin - http://www.hugingroup.com/ webmaster@novartis.com webmaster@novartis.com sø., 14 mars 2010 13:00:46 +0100 10 <![CDATA[Novartis International AG]]> http://www.novartis.com/images/novartis_logo.jpg http://www.novartis.com 195 98 <![CDATA[NAVIGATOR shows valsartan delayed progression to type 2 diabetes in at-risk cardiovascular patients with impaired glucose tolerance]]> Sun, 14 Mar 2010 13:00:00 +0100 http://cws.huginonline.com/N/134323/PR/201003/1393715_5.html Novartis International AG <![CDATA[Novartis announces USD 5 billion bond issue]]> Wed, 10 Mar 2010 07:15:00 +0100 http://cws.huginonline.com/N/134323/PR/201003/1392318_5.html Novartis International AG <![CDATA[Shareholders approve all proposed resolutions of Novartis Board of Directors]]> Fri, 26 Feb 2010 17:30:00 +0100 http://cws.huginonline.com/N/134323/PR/201002/1389239_5.html Novartis International AG <![CDATA[Novartis oral multiple sclerosis development compound Gilenia®* (FTY720) granted US priority review status]]> Mon, 22 Feb 2010 07:15:00 +0100 http://cws.huginonline.com/N/134323/PR/201002/1386852_5.html Novartis International AG <![CDATA[Novartis receives FDA approval of Menveo®, a vaccine to prevent meningococcal disease]]> Mon, 22 Feb 2010 07:05:00 +0100 http://cws.huginonline.com/N/134323/PR/201002/1386845_5.html Novartis International AG <![CDATA[Novartis drug Tasigna® receives FDA priority review for newly diagnosed patients with early-stage chronic myeloid leukemia]]> Fri, 19 Feb 2010 07:15:00 +0100 http://cws.huginonline.com/N/134323/PR/201002/1386313_5.html Novartis International AG <![CDATA[Novartis gains exclusive rights to Debio 025, an antiviral agent in Phase IIb development as potential first-in-class hepatitis C therapy]]> Tue, 9 Feb 2010 07:15:00 +0100 http://cws.huginonline.com/N/134323/PR/201002/1381968_5.html Novartis International AG <![CDATA[Novartis achieves record results in 2009 as momentum from recently launched products drives growth across its entire healthcare portfolio]]> Tue, 26 Jan 2010 07:00:00 +0100 http://cws.huginonline.com/N/134323/PR/201001/1377026_5.html Novartis International AG <![CDATA[Novartis oral MS therapy FTY720 shows reduced risk of confirmed disability progression as published in New England Journal of Medicine]]> Wed, 20 Jan 2010 23:05:00 +0100 http://cws.huginonline.com/N/134323/PR/201001/1375459_5.html Novartis International AG <![CDATA[Three new Novartis medicines approved in Japan for patients with type 2 diabetes, high blood pressure and advanced kidney cancer]]> Wed, 20 Jan 2010 07:15:00 +0100 http://cws.huginonline.com/N/134323/PR/201001/1375090_5.html Novartis International AG <![CDATA[Novartis providing equivalent of over USD 2.5 million in immediate emergency aid for victims of Haiti earthquake]]> Mon, 18 Jan 2010 07:15:00 +0100 http://cws.huginonline.com/N/134323/PR/201001/1374141_5.html Novartis International AG <![CDATA[Novartis launches schizophrenia treatment Fanapt in the US, offering patients an attractive alternative to existing medications]]> Mon, 11 Jan 2010 07:15:00 +0100 http://cws.huginonline.com/N/134323/PR/201001/1371914_5.html Novartis International AG <![CDATA[Novartis to acquire majority control of Alcon, a global leader in eye care, and proposes merger for full ownership]]> Mon, 4 Jan 2010 07:15:00 +0100 http://cws.huginonline.com/N/134323/PR/201001/1369739_5.html Novartis International AG <![CDATA[Novartis to acquire Corthera Inc., gaining worldwide rights to Phase III project relaxin for treatment of acute decompensated heart failure]]> Wed, 23 Dec 2009 07:15:00 +0100 http://cws.huginonline.com/N/134323/PR/200912/1366823_5.html Novartis International AG <![CDATA[All three Novartis A(H1N1) 2009 influenza vaccines prequalified by World Health Organization (WHO) for use in developing world]]> Mon, 21 Dec 2009 07:15:00 +0100 http://cws.huginonline.com/N/134323/PR/200912/1365351_5.html Novartis International AG <![CDATA[Novartis meningococcal vaccine Menveo® recommended for approval in the European Union for prevention of disease in adolescents and adults]]> Fri, 18 Dec 2009 15:24:29 +0100 http://cws.huginonline.com/N/134323/PR/200912/1365021_5.html Novartis International AG <![CDATA[Novartis set to sustain its leading global position in oncology with portfolio targeting various tumors and life-threatening diseases]]> Wed, 9 Dec 2009 07:00:00 +0100 http://cws.huginonline.com/N/134323/PR/200912/1359994_5.html Novartis International AG <![CDATA[Novartis Tasigna® trial shows superior results to Glivec® in patients with early-stage chronic myeloid leukemia]]> Tue, 8 Dec 2009 14:30:00 +0100 http://cws.huginonline.com/N/134323/PR/200912/1359764_5.html Novartis International AG <![CDATA[Novartis receives approval in the European Union for Onbrez® Breezhaler®, a new once-daily bronchodilator for patients with COPD]]> Thu, 3 Dec 2009 07:15:00 +0100 http://cws.huginonline.com/N/134323/PR/200912/1358846_5.html Novartis International AG <![CDATA[''Tackling the crisis with a new world economic ethics'': experts debate at the Novartis Foundation Symposium in Basel, Switzerland]]> Fri, 27 Nov 2009 09:18:35 +0100 http://cws.huginonline.com/N/134323/PR/200911/1357596_5.html Novartis International AG <![CDATA[Novartis gains rights to two oral targeted investigational therapies focusing on patients with life-threatening blood disorders and cancers]]> Wed, 25 Nov 2009 07:15:00 +0100 http://cws.huginonline.com/N/134323/PR/200911/1357027_5.html Novartis International AG <![CDATA[Novartis inaugurates large-scale US based cell-culture influenza vaccine manufacturing facility]]> Tue, 24 Nov 2009 07:15:00 +0100 http://cws.huginonline.com/N/134323/PR/200911/1356789_5.html Novartis International AG <![CDATA[Novartis Influenza A(H1N1) 2009 vaccine US interim data show lower doses of antigen may suffice to generate a protective immune response against A(H1N1) ]]> Tue, 17 Nov 2009 07:15:00 +0100 http://cws.huginonline.com/N/134323/PR/200911/1355458_5.html Novartis International AG <![CDATA[Novartis receives approval in Switzerland for Celtura®, a cell culture-based Influenza A(H1N1) pandemic vaccine ]]> Fri, 13 Nov 2009 16:41:22 +0100 http://cws.huginonline.com/N/134323/PR/200911/1355007_5.html Novartis International AG <![CDATA[Novartis launches Prevacid®24HR over-the-counter for full 24-hour frequent heartburn treatment]]> Thu, 12 Nov 2009 07:15:00 +0100 http://cws.huginonline.com/N/134323/PR/200911/1354451_5.html Novartis International AG <![CDATA[Novartis receives regulatory approval in Germany for Celtura®, a cell culture-based Influenza A(H1N1) pandemic vaccine]]> Thu, 5 Nov 2009 07:15:00 +0100 http://cws.huginonline.com/N/134323/PR/200911/1352736_5.html Novartis International AG <![CDATA[Novartis to expand its human vaccines presence in China through proposed acquisition of a majority stake in Zhejiang Tianyuan]]> Wed, 4 Nov 2009 07:00:00 +0100 http://cws.huginonline.com/N/134323/PR/200911/1352376_5.html Novartis International AG <![CDATA[Novartis announces USD 1 billion investment to build largest pharmaceutical R&D institute in China]]> Tue, 3 Nov 2009 07:15:00 +0100 http://cws.huginonline.com/N/134323/PR/200911/1352116_5.html Novartis International AG <![CDATA[Novartis on track to deliver Influenza A (H1N1) vaccine for the US]]> Thu, 29 Oct 2009 07:15:00 +0100 http://cws.huginonline.com/N/134323/PR/200910/1351038_5.html Novartis International AG <![CDATA[Novartis biological drug Ilaris® approved in EU to treat children and adults with CAPS, a rare debilitating auto-inflammatory disease]]> Wed, 28 Oct 2009 07:15:00 +0100 http://cws.huginonline.com/N/134323/PR/200910/1350596_5.html Novartis International AG <![CDATA[Novartis receives approval in the European Union for Exforge HCT®, a new 3-in-1 treatment for high blood pressure]]> Fri, 23 Oct 2009 07:15:00 +0200 http://cws.huginonline.com/N/134323/PR/200910/1349636_5.html Novartis International AG <![CDATA[Novartis delivers strong new product momentum and operational performance in first nine months of 2009]]> Thu, 22 Oct 2009 06:59:00 +0200 http://cws.huginonline.com/N/134323/PR/200910/1349248_5.html Novartis International AG <![CDATA[New Phase II data show ACZ885 gave better pain relief and flare prevention for patients with chronic gout than an injectable corticosteroid]]> Tue, 20 Oct 2009 07:15:00 +0200 http://cws.huginonline.com/N/134323/PR/200910/1348439_5.html Novartis International AG <![CDATA[Novartis drug Tasigna® meets primary endpoint in pivotal trial against Glivec® as first-line treatment in chronic myeloid leukemia patients]]> Tue, 20 Oct 2009 07:00:00 +0200 http://cws.huginonline.com/N/134323/PR/200910/1348449_5.html Novartis International AG <![CDATA[Novartis receives Complete Response letter from FDA for QAB149, an investigational bronchodilator for COPD]]> Mon, 19 Oct 2009 07:15:00 +0200 http://cws.huginonline.com/N/134323/PR/200910/1348153_5.html Novartis International AG <![CDATA[Leading Dengue and TB scientists discuss new clinical research approaches and models of excellence for clinical research and trials in endemic regions]]> Mon, 19 Oct 2009 07:00:00 +0200 http://cws.huginonline.com/N/134323/PR/200910/1348156_5.html Novartis International AG <![CDATA[Novartis enters into agreement for exclusive US and Canadian rights to Fanapt(TM), an FDA-approved oral therapy for schizophrenia]]> Mon, 12 Oct 2009 23:59:00 +0200 http://cws.huginonline.com/N/134323/PR/200910/1346595_5.html Novartis International AG <![CDATA[Novartis gains exclusive worldwide rights to PTK 0796, in Phase III study as potential first-in-class IV and oral broad-spectrum antibiotic]]> Thu, 8 Oct 2009 07:15:00 +0200 http://cws.huginonline.com/N/134323/PR/200910/1346369_5.html Novartis International AG <![CDATA[Novartis completes shipment of US supply of Fluvirin® seasonal influenza vaccine]]> Tue, 6 Oct 2009 07:15:00 +0200 http://cws.huginonline.com/N/134323/PR/200910/1345850_5.html Novartis International AG <![CDATA[Sandoz launches somatropin, the first-ever Japanese biosimilar, increasing access to key medicines in second largest global market ]]> Mon, 5 Oct 2009 08:33:19 +0200 http://cws.huginonline.com/N/134323/PR/200910/1345623_5.html Novartis International AG <![CDATA[Two-year Phase III study shows Novartis oral MS therapy FTY720 significantly reduces relapses and disability progression]]> Wed, 30 Sep 2009 07:15:00 +0200 http://cws.huginonline.com/N/134323/PR/200909/1344775_5.html Novartis International AG <![CDATA[Novartis bronchodilator QAB149 recommended for approval in European Union to treat patients with chronic obstructive pulmonary disease]]> Fri, 25 Sep 2009 17:20:00 +0200 http://cws.huginonline.com/N/134323/PR/200909/1343682_5.html Novartis International AG <![CDATA[Novartis A(H1N1) Pandemic Influenza vaccine Focetria® receives positive opinion from CHMP]]> Fri, 25 Sep 2009 11:29:47 +0200 http://cws.huginonline.com/N/134323/PR/200909/1343650_5.html Novartis International AG <![CDATA[Sandoz completes acquisition of EBEWE Pharma, improving global patient access to affordable injectable cancer medicines]]> Thu, 24 Sep 2009 07:15:00 +0200 http://cws.huginonline.com/N/134323/PR/200909/1343289_5.html Novartis International AG <![CDATA[Novartis receives FDA approval for Valturna®, a single-pill combination of valsartan and aliskiren, to treat high blood pressure ]]> Thu, 17 Sep 2009 22:00:00 +0200 http://cws.huginonline.com/N/134323/PR/200909/1342100_5.html Novartis International AG <![CDATA[Novartis investigational bronchodilator QAB149 improves lung function and reduces breathlessness compared to tiotropium in patients with COPD]]> Tue, 15 Sep 2009 07:00:00 +0200 http://cws.huginonline.com/N/134323/PR/200909/1341238_5.html Novartis International AG <![CDATA[Novartis MF59® adjuvanted cell culture-based vaccine shows strong immune response in A(H1N1) clinical trials]]> Thu, 3 Sep 2009 07:15:00 +0200 http://cws.huginonline.com/N/134323/PR/200909/1339223_5.html Novartis International AG <![CDATA[Novartis hosts scientific symposium in Philippines to review research approaches, clinical management, and growing presence of Dengue]]> Tue, 1 Sep 2009 07:15:00 +0200 http://cws.huginonline.com/N/134323/PR/200909/1338499_5.html Novartis International AG <![CDATA[Novartis receives approval in EU for Xolair® to treat children age 6 to 11 years suffering from severe persistent allergic asthma ]]> Mon, 24 Aug 2009 07:15:00 +0200 http://cws.huginonline.com/N/134323/PR/200908/1336542_5.html Novartis International AG <![CDATA[Novartis unveils Lab of Future concept to top European students at Biotechnology Leadership Camp (BioCamp)]]> Mon, 24 Aug 2009 07:15:00 +0200 http://cws.huginonline.com/N/134323/PR/200908/1336516_5.html Novartis International AG <![CDATA[Results in The New England Journal of Medicine confirm Novartis drug Femara® is superior to tamoxifen after breast cancer surgery]]> Wed, 19 Aug 2009 23:00:00 +0200 http://cws.huginonline.com/N/134323/PR/200908/1335978_5.html Novartis International AG <![CDATA[US FDA approves Extavia® - the first in a new portfolio of planned MS therapies from Novartis to help patients with this devastating disease]]> Mon, 17 Aug 2009 07:15:00 +0200 http://cws.huginonline.com/N/134323/PR/200908/1335044_5.html Novartis International AG <![CDATA[Sandoz launches first generic version of Prograf® capsules]]> Tue, 11 Aug 2009 07:15:00 +0200 http://cws.huginonline.com/N/134323/PR/200908/1333786_5.html Novartis International AG <![CDATA[Afinitor® approved in EU as first treatment proven to benefit patients with advanced kidney cancer after failure of targeted therapy]]> Thu, 6 Aug 2009 07:15:00 +0200 http://cws.huginonline.com/N/134323/PR/200908/1332932_5.html Novartis International AG <![CDATA[Novartis begins shipment of Fluvirin® seasonal influenza vaccine for the U.S. market ahead of schedule]]> Wed, 5 Aug 2009 07:15:00 +0200 http://cws.huginonline.com/N/134323/PR/200908/1332676_5.html Novartis International AG <![CDATA[Ilaris® recommended for European approval as new biologic drug to treat a rare but serious group of auto-inflammatory diseases]]> Fri, 24 Jul 2009 12:45:00 +0200 http://cws.huginonline.com/N/134323/PR/200907/1330801_5.html Novartis International AG <![CDATA[FDA approves Tekturna HCT® as initial treatment in patients unlikely to achieve their blood pressure goal with a single agent]]> Tue, 21 Jul 2009 07:15:00 +0200 http://cws.huginonline.com/N/134323/PR/200907/1329924_5.html Novartis International AG <![CDATA[Novartis delivers strong operational performance in the first half of 2009 driven by sustained Pharmaceuticals innovation]]> Thu, 16 Jul 2009 06:59:00 +0200 http://cws.huginonline.com/N/134323/PR/200907/1329090_5.html Novartis International AG <![CDATA[Japanese Ministry of Health approves Rasilez®, a first-in-class direct renin inhibitor (DRI), for the treatment of high blood pressure]]> Wed, 8 Jul 2009 07:00:00 +0200 http://cws.huginonline.com/N/134323/PR/200907/1327640_5.html Novartis International AG <![CDATA[Novartis extends tuberculosis drug donation to Tanzania]]> Tue, 7 Jul 2009 07:15:00 +0200 http://cws.huginonline.com/N/134323/PR/200907/1327425_5.html Novartis International AG <![CDATA[Novartis delivers 250,000,000th Coartem® treatment and becomes first healthcare company to join United Against Malaria partnership]]> Mon, 6 Jul 2009 07:15:00 +0200 http://cws.huginonline.com/N/134323/PR/200907/1327203_5.html Novartis International AG <![CDATA[Novartis receives Complete Response letter from the US Food and Drug Administration for its investigational vaccine Menveo®]]> Wed, 1 Jul 2009 02:10:21 +0200 http://cws.huginonline.com/N/134323/PR/200907/1326284_5.html Novartis International AG <![CDATA[Once-yearly Aclasta® approved in EU to treat osteoporosis caused by steroid treatment in men and postmenopausal women]]> Fri, 26 Jun 2009 07:15:00 +0200 http://cws.huginonline.com/N/134323/PR/200906/1325101_5.html Novartis International AG <![CDATA[Sandoz receives approval for first-ever Japanese biosimilar]]> Thu, 25 Jun 2009 07:15:00 +0200 http://cws.huginonline.com/N/134323/PR/200906/1324821_5.html Novartis International AG <![CDATA[Afinitor® and Sandostatin® LAR® Phase II data show advanced pancreatic NET patients remain progression-free for nearly 17 months]]> Wed, 24 Jun 2009 17:30:00 +0200 http://cws.huginonline.com/N/134323/PR/200906/1324661_5.html Novartis International AG <![CDATA[New biological therapy Ilaris® approved in US to treat children and adults with CAPS, a serious life-long auto-inflammatory disease]]> Thu, 18 Jun 2009 07:15:00 +0200 http://cws.huginonline.com/N/134323/PR/200906/1323528_5.html Novartis International AG <![CDATA[Novartis successfully demonstrates capabilities of cell-based technology for production of A(H1N1) vaccine]]> Fri, 12 Jun 2009 07:15:00 +0200 http://cws.huginonline.com/N/134323/PR/200906/1322241_5.html Novartis International AG <![CDATA[Afinitor® Phase II data show positive results for patients with multiple types of lymphoma, leading to Phase III trial]]> Mon, 8 Jun 2009 07:15:00 +0200 http://cws.huginonline.com/N/134323/PR/200906/1320856_5.html Novartis International AG <![CDATA[Tasigna® shows rapid and deep responses in newly diagnosed patients with a form of chronic myeloid leukemia]]> Fri, 5 Jun 2009 07:15:00 +0200 http://cws.huginonline.com/N/134323/PR/200906/1320149_5.html Novartis International AG <![CDATA[Novartis announces typhoid vaccine research program in partnership with the Wellcome Trust]]> Thu, 4 Jun 2009 07:15:00 +0200 http://cws.huginonline.com/N/134323/PR/200906/1319838_5.html Novartis International AG <![CDATA[One-year Phase III study confirms Ilaris® offers long-term remission in patients with CAPS, a severe lifelong auto-inflammatory disease]]> Wed, 3 Jun 2009 23:00:00 +0200 http://cws.huginonline.com/N/134323/PR/200906/1319771_5.html Novartis International AG <![CDATA[Novartis successfully launches EUR 1.5 billion notes issue]]> Tue, 2 Jun 2009 18:02:00 +0200 http://cws.huginonline.com/N/134323/PR/200906/1319318_5.html Novartis International AG <![CDATA[FDA approves Reclast® to prevent osteoporosis in postmenopausal women with convenient less frequent dosing]]> Mon, 1 Jun 2009 07:00:00 +0200 http://cws.huginonline.com/N/134323/PR/200906/1318842_5.html Novartis International AG <![CDATA[Afinitor® recommended for use in the European Union for patients with advanced kidney cancer ]]> Fri, 29 May 2009 18:24:32 +0200 http://cws.huginonline.com/N/134323/PR/200905/1318767_5.html Novartis International AG <![CDATA[Data on more than 15 Novartis Oncology compounds at ASCO highlight progress toward targeted therapies for diverse tumor types]]> Thu, 28 May 2009 07:15:00 +0200 http://cws.huginonline.com/N/134323/PR/200905/1318019_5.html Novartis International AG <![CDATA[Novartis increases its offer price on Novartis India Ltd.]]> Thu, 28 May 2009 02:30:00 +0200 http://cws.huginonline.com/N/134323/PR/200905/1318048_5.html Novartis International AG <![CDATA[Novartis to enter Japan vaccines market through agreement for Haemophilus Influenzae Type B (Hib) vaccine]]> Tue, 26 May 2009 17:30:00 +0200 http://cws.huginonline.com/N/134323/PR/200905/1317593_5.html Novartis International AG <![CDATA[Phase III data show Novartis investigational bronchodilator QAB149 significantly improves lung function over current treatments in COPD[1],[2]]]> Thu, 21 May 2009 07:00:00 +0200 http://cws.huginonline.com/N/134323/PR/200905/1316936_5.html Novartis International AG <![CDATA[Sandoz to acquire EBEWE Pharma specialty generics business, improving access for patients worldwide to injectable cancer drugs]]> Wed, 20 May 2009 07:15:00 +0200 http://cws.huginonline.com/N/134323/PR/200905/1316498_5.html Novartis International AG <![CDATA[Novartis announces restructuring of global collaboration with Schering-Plough to develop fixed-dose combination respiratory therapies]]> Tue, 19 May 2009 07:00:00 +0200 http://cws.huginonline.com/N/134323/PR/200905/1316055_5.html Novartis International AG <![CDATA[Novartis receives approval from FDA to market Prevacid®24HR as first and only OTC proton pump inhibitor in original formulation]]> Thu, 14 May 2009 07:15:00 +0200 http://cws.huginonline.com/N/134323/PR/200905/1314777_5.html Novartis International AG <![CDATA[Scientists who developed Novartis Coartem® and Glivec® receive 2009 ''European Inventor of the Year'' awards]]> Wed, 13 May 2009 17:30:00 +0200 http://cws.huginonline.com/N/134323/PR/200905/1314511_5.html Novartis International AG <![CDATA[Novartis names Jonathan Symonds deputy CFO and CFO designate]]> Wed, 13 May 2009 07:15:00 +0200 http://cws.huginonline.com/N/134323/PR/200905/1314149_5.html Novartis International AG <![CDATA[Glivec® approved in EU as first post-surgery therapy to reduce risk of cancer returning in patients with aggressive gastrointestinal tumors]]> Thu, 7 May 2009 07:15:00 +0200 http://cws.huginonline.com/N/134323/PR/200905/1311895_5.html Novartis International AG <![CDATA[FDA approves Exforge HCT® - the only high blood pressure treatment to combine three medications in a single pill]]> Thu, 30 Apr 2009 22:05:00 +0200 http://cws.huginonline.com/N/134323/PR/200904/1310474_5.html Novartis International AG <![CDATA[Novartis investigational adjuvanted (MF59) pre-pandemic avian influenza vaccine Aflunov® shows long lasting, broadly cross-protective immune response]]> Thu, 30 Apr 2009 08:18:20 +0200 http://cws.huginonline.com/N/134323/PR/200904/1310049_5.html Novartis International AG <![CDATA[New data presented at American Academy of Neurology congress show 80-83% of MS patients on oral FTY720 were relapse-free for one year - significantly better than a leading current treatment]]> Wed, 29 Apr 2009 07:00:00 +0200 http://cws.huginonline.com/N/134323/PR/200904/1309396_5.html Novartis International AG <![CDATA[Pharmaceuticals delivers strong underlying growth in first quarter of 2009 as Novartis continues to rejuvenate product portfolio]]> Thu, 23 Apr 2009 06:59:00 +0200 http://cws.huginonline.com/N/134323/PR/200904/1329178_5.html Novartis International AG <![CDATA[Coartem® receives FDA approval becoming first artemisinin-based combination treatment (ACT) for malaria in the US]]> Wed, 8 Apr 2009 18:40:20 +0200 http://cws.huginonline.com/N/134323/PR/200904/1304377_5.html Novartis International AG <![CDATA[Ixiaro® vaccine receives Marketing Authorization in Europe for the prevention of Japanese Encephalitis]]> Thu, 2 Apr 2009 17:30:00 +0200 http://cws.huginonline.com/N/134323/PR/200904/1303085_5.html Novartis International AG <![CDATA[Ixiaro® receives FDA approval for the prevention of Japanese Encephalitis]]> Mon, 30 Mar 2009 23:27:57 +0200 http://cws.huginonline.com/N/134323/PR/200903/1301829_5.html Novartis International AG <![CDATA[Afinitor® approved in US as first treatment for patients with advanced kidney cancer after failure of either sunitinib or sorafenib]]> Mon, 30 Mar 2009 21:30:00 +0200 http://cws.huginonline.com/N/134323/PR/200903/1301801_5.html Novartis International AG <![CDATA[Novartis makes an open offer to increase stake in Novartis India Ltd.]]> Wed, 25 Mar 2009 02:00:00 +0100 http://cws.huginonline.com/N/134323/PR/200903/1300166_5.html Novartis International AG <![CDATA[Glivec® recommended for use in Europe as first post-surgery treatment for gastrointestinal stromal tumors (GIST)]]> Thu, 19 Mar 2009 17:43:00 +0100 http://cws.huginonline.com/N/134323/PR/200903/1299087_5.html Novartis International AG <![CDATA[Glivec® substantially reduces risk of cancer returning in patients with life-threatening gastrointestinal stromal tumors, The Lancet reports]]> Wed, 18 Mar 2009 23:30:00 +0100 http://cws.huginonline.com/N/134323/PR/200903/1298635_5.html Novartis International AG <![CDATA[Novartis shareholders approve 25% dividend increase at 2009 Annual General Meeting]]> Tue, 24 Feb 2009 17:35:00 +0100 http://cws.huginonline.com/N/134323/PR/200902/1292900_5.html Novartis International AG <![CDATA[Sandoz receives European Commission approval for biosimilar filgrastim]]> Fri, 13 Feb 2009 07:15:00 +0100 http://cws.huginonline.com/N/134323/PR/200902/1290168_5.html Novartis International AG <![CDATA[Novartis gains worldwide rights to elinogrel, a Phase II anti-clotting compound with potential to reduce risk of heart attack and stroke]]> Thu, 12 Feb 2009 06:00:00 +0100 http://cws.huginonline.com/N/134323/PR/200902/1289667_5.html Novartis International AG <![CDATA[Zometa® reduces risk of breast cancer recurrence in premenopausal women, study in The New England Journal of Medicine reports]]> Wed, 11 Feb 2009 23:00:00 +0100 http://cws.huginonline.com/N/134323/PR/200902/1289425_5.html Novartis International AG <![CDATA[Novartis successfully launches USD 5 billion bond issue]]> Thu, 5 Feb 2009 07:15:00 +0100 http://cws.huginonline.com/N/134323/PR/200902/1287646_5.html Novartis International AG <![CDATA[Novartis increases dividend by 25% based on strong 2008 results from strategic healthcare portfolio]]> Wed, 28 Jan 2009 06:59:00 +0100 http://cws.huginonline.com/N/134323/PR/200901/1285325_5.html Novartis International AG <![CDATA[Novartis and Gen-Probe Agree to Extend and Expand Blood Screening Collaboration]]> Tue, 27 Jan 2009 22:00:00 +0100 http://cws.huginonline.com/N/134323/PR/200901/1285136_5.html Novartis International AG <![CDATA[Novartis and Medicines for Malaria Venture launch Coartem® Dispersible, the first ACT* developed for children suffering from malaria]]> Tue, 27 Jan 2009 07:15:00 +0100 http://cws.huginonline.com/N/134323/PR/200901/1284997_5.html Novartis International AG <![CDATA[Novartis launches Extavia®, a new therapeutic option to help patients combat devastating symptoms of multiple sclerosis]]> Thu, 22 Jan 2009 07:15:00 +0100 http://cws.huginonline.com/N/134323/PR/200901/1283987_5.html Novartis International AG <![CDATA[Four innovative Novartis medicines for cancer, asthma, high blood pressure and wet AMD approved in Japan]]> Wed, 21 Jan 2009 07:15:00 +0100 http://cws.huginonline.com/N/134323/PR/200901/1283705_5.html Novartis International AG <![CDATA[US Department of Health and Human Services awards Novartis USD 486 million contract to build manufacturing facility for pandemic flu vaccine]]> Thu, 15 Jan 2009 16:00:00 +0100 http://cws.huginonline.com/N/134323/PR/200901/1282432_5.html Novartis International AG <![CDATA[New study first to confirm Sandostatin® LAR® controls tumor growth in patients with rare gastrointestinal tumors ]]> Wed, 14 Jan 2009 00:00:00 +0100 http://cws.huginonline.com/N/134323/PR/200901/1281971_5.html Novartis International AG <![CDATA[Afinitor® Phase II trial results positive in patients with advanced gastric cancer after failure of one or more prior treatments ]]> Wed, 14 Jan 2009 00:00:00 +0100 http://cws.huginonline.com/N/134323/PR/200901/1281970_5.html Novartis International AG <![CDATA[Novartis strengthens vaccine pipeline with agreement for novel CMV vaccines candidate]]> Mon, 29 Dec 2008 07:15:00 +0100 http://cws.huginonline.com/N/134323/PR/200812/1279693_5.html Novartis International AG <![CDATA[Glivec receives US approval as first treatment to reduce risk of cancer returning in patients with gastrointestinal stromal tumors]]> Sat, 20 Dec 2008 02:14:19 +0100 http://cws.huginonline.com/N/134323/PR/200812/1279094_5.html Novartis International AG <![CDATA[Afinitor® shows potential to reverse resistance to Herceptin®[*] in metastatic breast cancer patients, leading to Phase III trial]]> Sat, 13 Dec 2008 00:00:00 +0100 http://cws.huginonline.com/N/134323/PR/200812/1277244_5.html Novartis International AG <![CDATA[First Phase III results for FTY720, a novel oral therapy for MS, show superior efficacy compared to interferon beta-1a]]> Fri, 12 Dec 2008 07:15:00 +0100 http://cws.huginonline.com/N/134323/PR/200812/1277020_5.html Novartis International AG <![CDATA[New data show Zometa® enhances impact of chemotherapy on reducing breast tumor size]]> Thu, 11 Dec 2008 21:00:00 +0100 http://cws.huginonline.com/N/134323/PR/200812/1276910_5.html Novartis International AG <![CDATA[Femara® first aromatase inhibitor to indicate survival benefit versus tamoxifen when taken for five years after breast cancer surgery]]> Thu, 11 Dec 2008 16:45:00 +0100 http://cws.huginonline.com/N/134323/PR/200812/1276719_5.html Novartis International AG <![CDATA[Novartis receives China Charity Award for relief efforts to Chinese earthquake victims]]> Thu, 11 Dec 2008 07:00:00 +0100 http://cws.huginonline.com/N/134323/PR/200812/1276717_5.html Novartis International AG <![CDATA[Exjade® benefits chronically transfused patients by significantly reducing toxic iron that can damage key organs, according to landmark trial]]> Tue, 9 Dec 2008 00:30:00 +0100 http://cws.huginonline.com/N/134323/PR/200812/1275815_5.html Novartis International AG <![CDATA[Tasigna® demonstrates rapid response as initial therapy in life-threatening form of leukemia]]> Mon, 8 Dec 2008 22:45:00 +0100 http://cws.huginonline.com/N/134323/PR/200812/1275790_5.html Novartis International AG <![CDATA[Novartis awards program continues to drive energy savings and environmental progress ]]> Thu, 4 Dec 2008 07:30:00 +0100 http://cws.huginonline.com/N/134323/PR/200812/1275054_5.html Novartis International AG <![CDATA[''Dare to dialog?'' - experts debate on the conditions of constructive stakeholder relations at this year's symposium of the Novartis Foundation for Sustainable Development]]> Thu, 4 Dec 2008 07:30:00 +0100 http://cws.huginonline.com/N/134323/PR/200812/1274761_5.html Novartis International AG <![CDATA[More than 200 abstracts at ASH and SABCS reveal potential compelling patient benefits from Novartis Oncology current and pipeline therapies]]> Thu, 4 Dec 2008 07:15:00 +0100 http://cws.huginonline.com/N/134323/PR/200812/1275058_5.html Novartis International AG <![CDATA[Sandoz receives positive EU opinion for biosimilar filgrastim ]]> Fri, 21 Nov 2008 12:48:00 +0100 http://cws.huginonline.com/N/134323/PR/200811/1272071_5.html Novartis International AG <![CDATA[Rasilez HCT® receives recommendation for European approval as a single-pill combination to treat high blood pressure]]> Fri, 21 Nov 2008 12:46:24 +0100 http://cws.huginonline.com/N/134323/PR/200811/1272035_5.html Novartis International AG <![CDATA[Novartis highlights innovative approach to drug discovery with dynamic advance in exploratory pipeline]]> Wed, 19 Nov 2008 07:00:00 +0100 http://cws.huginonline.com/N/134323/PR/200811/1271207_5.html Novartis International AG <![CDATA[Rasilez®, first-in-class direct renin inhibitor, provides greater reduction in high blood pressure than ACE inhibitor ramipril in patients 65 and older]]> Tue, 11 Nov 2008 17:30:00 +0100 http://cws.huginonline.com/N/134323/PR/200811/1268561_5.html Novartis International AG <![CDATA[Rasilez HCT®, single-pill combination of Rasilez® and diuretic, receives Swiss approval for the treatment of high blood pressure]]> Wed, 29 Oct 2008 07:15:00 +0100 http://cws.huginonline.com/N/134323/PR/200810/1264205_5.html Novartis International AG <![CDATA[ACZ885 Phase III data show rapid, sustained clinical remission in children and adults suffering from a group of rare, potentially life-threatening autoinflammatory diseases]]> Mon, 27 Oct 2008 07:15:00 +0100 http://cws.huginonline.com/N/134323/PR/200810/1263270_5.html Novartis International AG <![CDATA[Novartis to acquire Nektar Therapeutics pulmonary business unit, strengthening respiratory drug delivery capabilities]]> Tue, 21 Oct 2008 07:15:00 +0200 http://cws.huginonline.com/N/134323/PR/200810/1261361_5.html Novartis International AG <![CDATA[Novartis delivers sustained strong performance in first nine months of 2008 underpinned by accelerating growth in pharmaceuticals]]> Mon, 20 Oct 2008 07:00:00 +0200 http://cws.huginonline.com/N/134323/PR/200810/1260877_5.html Novartis International AG <![CDATA[Early data show potential for imatinib to treat life-threatening form of pulmonary artery disease]]> Wed, 8 Oct 2008 07:15:00 +0200 http://cws.huginonline.com/N/134323/PR/200810/1257684_5.html Novartis International AG <![CDATA[New Phase II data on NVA237, a novel once-daily treatment for COPD, show promising efficacy and tolerability with potentially faster onset than tiotropium]]> Tue, 7 Oct 2008 07:15:00 +0200 http://cws.huginonline.com/N/134323/PR/200810/1257283_5.html Novartis International AG <![CDATA[New study shows potential benefits of innovative Xolair® anti-IgE therapy in treating children suffering from moderate-to-severe allergic asthma ]]> Mon, 6 Oct 2008 07:15:00 +0200 http://cws.huginonline.com/N/134323/PR/200810/1257049_5.html Novartis International AG <![CDATA[Once-yearly Aclasta® approved in EU to treat osteoporosis in men and to reduce risk of new fractures following hip fracture both in men and postmenopausal women]]> Tue, 30 Sep 2008 07:15:00 +0200 http://cws.huginonline.com/N/134323/PR/200809/1255392_5.html Novartis International AG <![CDATA[Novartis starts ''squeeze out'' procedure for remaining Speedel shares]]> Thu, 25 Sep 2008 07:15:00 +0200 http://cws.huginonline.com/N/134323/PR/200809/1254262_5.html Novartis International AG <![CDATA[Novartis MF59®-adjuvanted vaccine rapidly induces protective antibody levels against diverse strains of avian flu ]]> Fri, 19 Sep 2008 07:15:00 +0200 http://cws.huginonline.com/N/134323/PR/200809/1252754_5.html Novartis International AG <![CDATA[Latest RAD001 study results show further increase in time without tumor growth in patients with advanced kidney cancer]]> Tue, 16 Sep 2008 07:15:00 +0200 http://cws.huginonline.com/N/134323/PR/200809/1251556_5.html Novartis International AG <![CDATA[Novartis receives FDA priority review for Coartem®, potentially the first artemisinin-based combination treatment (ACT) for malaria in the US]]> Mon, 15 Sep 2008 07:15:00 +0200 http://cws.huginonline.com/N/134323/PR/200809/1251164_5.html Novartis International AG <![CDATA[RAD001 combined with Sandostatin® LAR® and as monotherapy controls growth of rare pancreatic neuroendocrine tumors]]> Sat, 13 Sep 2008 12:45:00 +0200 http://cws.huginonline.com/N/134323/PR/200809/1251089_5.html Novartis International AG <![CDATA[New Phase II data show Novartis investigational Meningitis B vaccine may also protect infants six months and older]]> Wed, 10 Sep 2008 07:15:00 +0200 http://cws.huginonline.com/N/134323/PR/200809/1250239_5.html Novartis International AG <![CDATA[Data show Galvus® better tolerated by patients with type 2 diabetes, with no weight gain, a favorable cardiovascular profile and equal efficacy compared to widely-used TZDs ]]> Tue, 9 Sep 2008 17:30:00 +0200 http://cws.huginonline.com/N/134323/PR/200809/1249901_5.html Novartis International AG <![CDATA[RAD001 granted priority review in the US based on potential to fill unmet medical need in patients with advanced kidney cancer]]> Tue, 9 Sep 2008 07:15:00 +0200 http://cws.huginonline.com/N/134323/PR/200809/1249860_5.html Novartis International AG <![CDATA[Rasilez® , first-in-class direct renin inhibitor, lowers high blood pressure more effectively than diuretic in obese patients]]> Wed, 3 Sep 2008 12:35:00 +0200 http://cws.huginonline.com/N/134323/PR/200809/1248468_5.html Novartis International AG <![CDATA[Sandoz receives FDA approval for Omnitrope® Pen 10 with liquid cartridge]]> Wed, 3 Sep 2008 07:15:00 +0200 http://cws.huginonline.com/N/134323/PR/200809/1248342_5.html Novartis International AG <![CDATA[Novartis decides not to pursue further development of Aurograb(TM) ]]> Fri, 29 Aug 2008 07:15:00 +0200 http://cws.huginonline.com/N/134323/PR/200808/1247203_5.html Novartis International AG <![CDATA[Glivec receives FDA priority review as first therapy to reduce recurrence of gastrointestinal stromal tumors after surgery]]> Wed, 27 Aug 2008 07:15:00 +0200 http://cws.huginonline.com/N/134323/PR/200808/1246407_5.html Novartis International AG <![CDATA[NICE final guidance recommends Lucentis® as cost-effective treatment for wet AMD, a leading cause of blindness]]> Wed, 27 Aug 2008 01:02:00 +0200 http://cws.huginonline.com/N/134323/PR/200808/1246393_5.html Novartis International AG <![CDATA[Novartis begins shipment to US of Fluvirin® Influenza Virus Vaccine with three new strains for the 2008-2009 influenza season]]> Thu, 7 Aug 2008 07:15:00 +0200 http://cws.huginonline.com/N/134323/PR/200808/1241557_5.html Novartis International AG <![CDATA[Single-pill combinations Diovan HCT® and Exforge® approved in US as first-line treatments for high blood pressure]]> Mon, 4 Aug 2008 07:15:00 +0200 http://cws.huginonline.com/N/134323/PR/200808/1239786_5.html Novartis International AG <![CDATA[Exforge® helps nearly twice as many patients control their high blood pressure compared to amlodipine alone ]]> Mon, 28 Jul 2008 07:15:00 +0200 http://cws.huginonline.com/N/134323/PR/200807/1238536_5.html Novartis International AG <![CDATA[Once-yearly Aclasta® recommended in EU to treat male osteoporosis and reduce risk of new fractures in patients after hip fracture]]> Fri, 25 Jul 2008 12:37:00 +0200 http://cws.huginonline.com/N/134323/PR/200807/1238453_5.html Novartis International AG <![CDATA[Novartis gains momentum with strong performance in first half of 2008 from portfolio focused on growth areas of healthcare]]> Thu, 17 Jul 2008 07:00:00 +0200 http://cws.huginonline.com/N/134323/PR/200807/1236488_5.html Novartis International AG <![CDATA[Novartis enters strategic partnership with Lonza to accelerate growth of biologics pipeline]]> Fri, 11 Jul 2008 07:15:00 +0200 http://cws.huginonline.com/N/134323/PR/200807/1235238_5.html Novartis International AG <![CDATA[Novartis buys additional 51.7% stake in Speedel and announces plans to acquire remaining shares in a mandatory public tender offer]]> Thu, 10 Jul 2008 07:00:00 +0200 http://cws.huginonline.com/N/134323/PR/200807/1234914_5.html Novartis International AG <![CDATA[Novartis completes acquisition of 25% stake in Alcon from Nestlé, first step toward majority ownership of the world leader in eye care]]> Tue, 8 Jul 2008 07:30:00 +0200 http://cws.huginonline.com/N/134323/PR/200807/1234280_5.html Novartis International AG <![CDATA[Novartis Pharmaceuticals Corporation to Appeal Judgment in Alabama Pricing Case]]> Wed, 2 Jul 2008 01:16:00 +0200 http://cws.huginonline.com/N/134323/PR/200807/1232992_5.html Novartis International AG <![CDATA[Novartis Institute for Tropical Diseases and Global Alliance for TB Drug Development announce five-year collaboration targeted to accelerate TB treatment R&D]]> Tue, 24 Jun 2008 07:15:00 +0200 http://cws.huginonline.com/N/134323/PR/200806/1230343_5.html Novartis International AG <![CDATA[Rasilez®[*] ASPIRE HIGHER clinical program expands to 35,000 patients in 14 trials, the largest cardio-renal outcomes program ever]]> Tue, 17 Jun 2008 07:15:00 +0200 http://cws.huginonline.com/N/134323/PR/200806/1228485_5.html Novartis International AG <![CDATA[Higher initial dose of Glivec achieved better early responses than standard dose for patients with chronic myeloid leukemia]]> Fri, 13 Jun 2008 07:30:00 +0200 http://cws.huginonline.com/N/134323/PR/200806/1227552_5.html Novartis International AG <![CDATA[Novartis recommends rejection of ''mini-tender'' offer by TRC Capital for American Depositary Shares ]]> Thu, 12 Jun 2008 07:15:00 +0200 http://cws.huginonline.com/N/134323/PR/200806/1227249_5.html Novartis International AG <![CDATA[Novartis successfully issues two Swiss franc benchmark bonds totaling CHF 1.5 billion ]]> Tue, 10 Jun 2008 20:07:00 +0200 http://cws.huginonline.com/N/134323/PR/200806/1226826_5.html Novartis International AG <![CDATA[Leading blood pressure medication Diovan® with diuretic reduces key sign of artery ageing which is linked to risk of heart attack and stroke]]> Thu, 5 Jun 2008 15:16:00 +0200 http://cws.huginonline.com/N/134323/PR/200806/1225571_5.html Novartis International AG <![CDATA[FDA broadens US indication for once-yearly Reclast® as only osteoporosis treatment approved for prevention of fractures after a hip fracture]]> Thu, 5 Jun 2008 07:15:00 +0200 http://cws.huginonline.com/N/134323/PR/200806/1225355_5.html Novartis International AG <![CDATA[New data show potential of Rasilez®* to protect kidneys from damage independent of its proven ability to lower blood pressure]]> Wed, 4 Jun 2008 23:00:00 +0200 http://cws.huginonline.com/N/134323/PR/200806/1225277_5.html Novartis International AG <![CDATA[Novartis gains rights to promising hospital antibiotic in clinical development through full acquisition of Protez Pharmaceuticals]]> Wed, 4 Jun 2008 07:30:00 +0200 http://cws.huginonline.com/N/134323/PR/200806/1224971_5.html Novartis International AG <![CDATA[Novartis presents full pipeline of novel vaccines addressing significant unmet needs]]> Wed, 4 Jun 2008 07:15:00 +0200 http://cws.huginonline.com/N/134323/PR/200806/1224970_5.html Novartis International AG <![CDATA[Early data presented at ASCO show potential of RAD001 to enhance efficacy of, and overcome resistance to, breast cancer treatments]]> Mon, 2 Jun 2008 07:15:00 +0200 http://cws.huginonline.com/N/134323/PR/200806/1224201_5.html Novartis International AG <![CDATA[Major independent trial demonstrates significant anticancer benefit of Zometa® in women with early-stage breast cancer]]> Sat, 31 May 2008 16:00:00 +0200 http://cws.huginonline.com/N/134323/PR/200805/1224091_5.html Novartis International AG <![CDATA[Extavia® approved in European Union for treatment of multiple sclerosis, first in planned portfolio of therapies from Novartis]]> Mon, 26 May 2008 07:15:00 +0200 http://cws.huginonline.com/N/134323/PR/200805/1222369_5.html Novartis International AG <![CDATA[RAD001 more than doubles time without tumor growth after failure of standard treatment in patients with advanced kidney cancer]]> Mon, 19 May 2008 07:15:00 +0200 http://cws.huginonline.com/N/134323/PR/200805/1220385_5.html Novartis International AG <![CDATA[Strength and innovation of Novartis Oncology products and pipeline with potential to improve patient treatment demonstrated by more than 170 abstracts at ASCO annual meeting]]> Thu, 15 May 2008 22:15:00 +0200 http://cws.huginonline.com/N/134323/PR/200805/1219879_5.html Novartis International AG <![CDATA[New data show Tekturna HCT® is twice as effective at reducing blood pressure than the diuretic HCT alone]]> Thu, 15 May 2008 07:15:00 +0200 http://cws.huginonline.com/N/134323/PR/200805/1219430_5.html Novartis International AG <![CDATA[In a Phase II study, Novartis Meningitis B vaccine has potential to produce a protective immune response in infants[1], the age group most at risk ]]> Wed, 14 May 2008 07:30:00 +0200 http://cws.huginonline.com/N/134323/PR/200805/1218899_5.html Novartis International AG <![CDATA[Significant blood pressure reductions seen in difficult-to-treat, black patients receiving Exforge®-based therapy[1]]]> Wed, 14 May 2008 07:15:00 +0200 http://cws.huginonline.com/N/134323/PR/200805/1218905_5.html Novartis International AG <![CDATA[Novartis Menveo® vaccine shows superior immune response against four types of meningitis disease in pivotal phase III trial]]> Tue, 6 May 2008 04:45:00 +0200 http://cws.huginonline.com/N/134323/PR/200805/1216115_5.html Novartis International AG <![CDATA[Breakthrough technique pioneered at Novartis research institute restores light sensitivity in damaged retinas ]]> Mon, 28 Apr 2008 17:10:00 +0200 http://cws.huginonline.com/N/134323/PR/200804/1214133_5.html Novartis International AG <![CDATA[Novartis announces 20% average reduction in price of malaria drug Coartem® to further accelerate access in malaria-endemic regions]]> Wed, 23 Apr 2008 07:15:00 +0200 http://cws.huginonline.com/N/134323/PR/200804/1212224_5.html Novartis International AG <![CDATA[Novartis reports higher sales and earnings in first quarter of 2008 showing healthcare portfolio well on the way to new growth cycle]]> Mon, 21 Apr 2008 07:00:00 +0200 http://cws.huginonline.com/N/134323/PR/200804/1211012_5.html Novartis International AG <![CDATA[FTY720, a novel oral therapy in development for MS, shows sustained benefits for the majority of patients after three years of treatment]]> Tue, 15 Apr 2008 22:45:00 +0200 http://cws.huginonline.com/N/134323/PR/200804/1209064_5.html Novartis International AG <![CDATA[Patients with early Parkinson's disease show better symptom control[1] and improvements in daily activities[1] with Stalevo than levodopa/carbidopa]]> Tue, 15 Apr 2008 14:00:00 +0200 http://cws.huginonline.com/N/134323/PR/200804/1209170_5.html Novartis International AG <![CDATA[Study shows once-yearly Aclasta® better than risedronate at increasing bone mass in patients with osteoporosis caused by glucocorticoids]]> Fri, 11 Apr 2008 15:30:00 +0200 http://cws.huginonline.com/N/134323/PR/200804/1208659_5.html Novartis International AG <![CDATA[ASA404, a novel cancer agent, begins pivotal trial to explore new approach in treating lung cancer, the leading cause of cancer death]]> Fri, 11 Apr 2008 07:15:00 +0200 http://cws.huginonline.com/N/134323/PR/200804/1208459_5.html Novartis International AG <![CDATA[ACZ885, a new biological drug in development, shows potential in treating serious life-long autoinflammatory diseases]]> Tue, 8 Apr 2008 10:52:00 +0200 http://cws.huginonline.com/N/134323/PR/200804/1207396_5.html Novartis International AG <![CDATA[Novartis to further strengthen its healthcare portfolio by acquiring 25% stake in Alcon from Nestlé with right to take over majority ownership of the world leader in eye care]]> Mon, 7 Apr 2008 07:30:00 +0200 http://cws.huginonline.com/N/134323/PR/200804/1206896_5.html Novartis International AG <![CDATA[Rasilez®* , the first-in-class direct renin inhibitor, reduces left ventricular hypertrophy, a powerful predictor of heart disease]]> Mon, 31 Mar 2008 20:02:00 +0200 http://cws.huginonline.com/N/134323/PR/200803/1205085_5.html Novartis International AG <![CDATA[Sandoz enhances patient access with launch of Omnitrope(TM) Pen 5 with liquid cartridge]]> Wed, 12 Mar 2008 07:15:00 +0100 http://cws.huginonline.com/N/134323/PR/200803/1200079_5.html Novartis International AG <![CDATA[Femara® helps protect against return of breast cancer even when treatment starts several years after completing tamoxifen therapy]]> Mon, 10 Mar 2008 23:00:00 +0100 http://cws.huginonline.com/N/134323/PR/200803/1199700_5.html Novartis International AG <![CDATA[Everolimus (RAD001) significantly extends progression-free survival in advanced kidney cancer patients after failure of other targeted therapy]]> Thu, 28 Feb 2008 07:00:00 +0100 http://cws.huginonline.com/N/134323/PR/200802/1196020_5.html Novartis International AG <![CDATA[Novartis shareholders approve all resolutions at 2008 Annual General Meeting, including 19% dividend increase ]]> Tue, 26 Feb 2008 16:46:00 +0100 http://cws.huginonline.com/N/134323/PR/200802/1195332_5.html Novartis International AG <![CDATA[Eucreas®, a single-tablet combination of Galvus® and metformin, set for launch in first EU countries as new treatment for type 2 diabetes]]> Mon, 25 Feb 2008 07:15:00 +0100 http://cws.huginonline.com/N/134323/PR/200802/1194564_5.html Novartis International AG <![CDATA[New Novartis Research Institute first to focus on innovative vaccines for the developing world]]> Fri, 22 Feb 2008 07:15:00 +0100 http://cws.huginonline.com/N/134323/PR/200802/1194139_5.html Novartis International AG <![CDATA[Novartis announces proposals for shareholder approval at next Annual General Meeting]]> Fri, 1 Feb 2008 07:30:00 +0100 http://cws.huginonline.com/N/134323/PR/200802/1187378_5.html Novartis International AG <![CDATA[Galvus®, a new treatment for patients with type 2 diabetes, receives European approval for label update paving the way for EU launches]]> Fri, 1 Feb 2008 07:15:00 +0100 http://cws.huginonline.com/N/134323/PR/200802/1187381_5.html Novartis International AG <![CDATA[Novartis files its Form 20-F annual report with the US Securities and Exchange Commission]]> Thu, 31 Jan 2008 08:01:00 +0100 http://cws.huginonline.com/N/134323/PR/200801/1186906_5.html Novartis International AG <![CDATA[Tekturna HCT®, a single-tablet combination of Tekturna®* and a diuretic, receives US approval for treatment of high blood pressure]]> Mon, 21 Jan 2008 07:15:00 +0100 http://cws.huginonline.com/N/134323/PR/200801/1183677_5.html Novartis International AG <![CDATA[Novartis achieves record results in 2007 underscoring benefits of strategic healthcare portfolio]]> Thu, 17 Jan 2008 07:00:00 +0100 http://cws.huginonline.com/N/134323/PR/200801/1182832_5.html Novartis International AG <![CDATA[New data show Menveo(TM) to be the first quadrivalent meningococcal vaccine to provide immunogenicity in infants]]> Tue, 8 Jan 2008 23:23:00 +0100 http://cws.huginonline.com/N/134323/PR/200801/1180471_5.html Novartis International AG <![CDATA[Galvus®, a new oral treatment for type 2 diabetes, receives positive opinion following changes to European prescribing information]]> Mon, 17 Dec 2007 07:15:00 +0100 http://cws.huginonline.com/N/134323/PR/200712/1176484_5.html Novartis International AG <![CDATA[Novartis launches strategic initiative to improve competitiveness in a dynamically changing healthcare environment]]> Thu, 13 Dec 2007 07:15:00 +0100 http://cws.huginonline.com/N/134323/PR/200712/1175700_5.html Novartis International AG <![CDATA[New data show Glivec® halts progression to advanced stages of life-threatening form of leukemia in sixth year of treatment]]> Sun, 9 Dec 2007 22:30:00 +0100 http://cws.huginonline.com/N/134323/PR/200712/1174545_5.html Novartis International AG <![CDATA[Novartis further strengthens biologics capabilities in expansion of MorphoSys collaboration]]> Sun, 2 Dec 2007 20:00:00 +0100 http://cws.huginonline.com/N/134323/PR/200712/1172383_5.html Novartis International AG <![CDATA[Novartis completes its fifth share repurchase program]]> Fri, 30 Nov 2007 17:15:00 +0100 http://cws.huginonline.com/N/134323/PR/200711/1172289_5.html Novartis International AG <![CDATA[Tasigna® gains European approval for patients with a life-threatening form of leukemia who are resistant or intolerant to existing therapies]]> Wed, 28 Nov 2007 07:15:00 +0100 http://cws.huginonline.com/N/134323/PR/200711/1171279_5.html Novartis International AG <![CDATA[CIBA Vision, the eye care unit of Novartis, announces settlement of patent litigation with CooperVision, Inc.]]> Wed, 21 Nov 2007 15:00:00 +0100 http://cws.huginonline.com/N/134323/PR/200711/1170014_5.html Novartis International AG <![CDATA[United Kingdom and Germany suspend marketing and sale of Prexige® pending outcome of European regulatory review]]> Mon, 19 Nov 2007 16:04:00 +0100 http://cws.huginonline.com/N/134323/PR/200711/1169462_5.html Novartis International AG <![CDATA[New data for Menveo(TM) vaccine show excellent immune response and broad protection for infants against meningococcal meningitis]]> Thu, 15 Nov 2007 07:15:00 +0100 http://cws.huginonline.com/N/134323/PR/200711/1168580_5.html Novartis International AG <![CDATA[New Galvus® clinical data reinforces efficacy profile; safety update provided to regulatory agencies]]> Tue, 6 Nov 2007 07:15:00 +0100 http://cws.huginonline.com/N/134323/PR/200711/1166139_5.html Novartis International AG <![CDATA[Tasigna® receives US approval providing new hope to chronic myeloid leukemia patients with resistance or intolerance to existing therapies]]> Mon, 29 Oct 2007 19:57:00 +0100 http://cws.huginonline.com/N/134323/PR/200710/1163903_5.html Novartis International AG <![CDATA[Voltaren® Gel receives US regulatory approval as the first approved topical prescription treatment for pain associated with osteoarthritis]]> Mon, 22 Oct 2007 07:15:00 +0200 http://cws.huginonline.com/N/134323/PR/200710/1161352_5.html Novartis International AG <![CDATA[Novartis delivers record earnings in first nine months of 2007 thanks to strong operational performance and divestment gains]]> Thu, 18 Oct 2007 07:00:00 +0200 http://cws.huginonline.com/N/134323/PR/200710/1160794_5.html Novartis International AG <![CDATA[Aclasta® receives European approval as first once-yearly treatment for postmenopausal osteoporosis ]]> Fri, 5 Oct 2007 07:15:00 +0200 http://cws.huginonline.com/N/134323/PR/200710/1158103_5.html Novartis International AG <![CDATA[Novartis and Massachusetts Institute of Technology (MIT) in new partnership aimed at transforming pharmaceutical manufacturing]]> Fri, 28 Sep 2007 13:13:00 +0200 http://cws.huginonline.com/N/134323/PR/200709/1156760_5.html Novartis International AG <![CDATA[Galvus® receives European approval as new treatment for type 2 diabetes with broad range of indications]]> Fri, 28 Sep 2007 07:15:00 +0200 http://cws.huginonline.com/N/134323/PR/200709/1156607_5.html Novartis International AG <![CDATA[Prexige® receives ''not approvable'' letter in the US despite being one of the most studied COX-2 inhibitors]]> Thu, 27 Sep 2007 07:15:00 +0200 http://cws.huginonline.com/N/134323/PR/200709/1156327_5.html Novartis International AG <![CDATA[Exelon® patch receives European Union approval, the first skin patch therapy to treat Alzheimer's disease]]> Mon, 24 Sep 2007 07:15:00 +0200 http://cws.huginonline.com/N/134323/PR/200709/1155385_5.html Novartis International AG <![CDATA[Tasigna® recommended for European approval to treat rare form of leukemia no longer responding to Glivec® ]]> Fri, 21 Sep 2007 13:35:00 +0200 http://cws.huginonline.com/N/134323/PR/200709/1155247_5.html Novartis International AG <![CDATA[Eucreas®, a single-tablet combination of Galvus® and metformin, recommended for EU approval for type 2 diabetes]]> Fri, 21 Sep 2007 13:35:00 +0200 http://cws.huginonline.com/N/134323/PR/200709/1155246_5.html Novartis International AG <![CDATA[First osteoporosis study in patients with hip fracture finds once-yearly Aclasta®-Reclast® prevents additional fractures and improves survival]]> Tue, 18 Sep 2007 05:00:00 +0200 http://cws.huginonline.com/N/134323/PR/200709/1154028_5.html Novartis International AG <![CDATA[New data for Galvus® provide further evidence of robust efficacy and tolerability in treating patients with type 2 diabetes]]> Mon, 17 Sep 2007 07:15:00 +0200 http://cws.huginonline.com/N/134323/PR/200709/1153741_5.html Novartis International AG <![CDATA[Novartis completes agreement with Bayer Schering related to Betaseron® rights and manufacturing]]> Fri, 14 Sep 2007 07:15:00 +0200 http://cws.huginonline.com/N/134323/PR/200709/1153481_5.html Novartis International AG <![CDATA[US federal appeals court temporarily stops Teva from selling its generic version of the Novartis medicine Famvir®]]> Mon, 10 Sep 2007 07:15:00 +0200 http://cws.huginonline.com/N/134323/PR/200709/1152398_5.html Novartis International AG <![CDATA[Novartis to defend its intellectual property rights for Famvir® despite an at-risk generic launch in US]]> Fri, 7 Sep 2007 19:15:00 +0200 http://cws.huginonline.com/N/134323/PR/200709/1152325_5.html Novartis International AG <![CDATA[Cubicin® receives European approval to expand use to treating two additional types of life-threatening hospital infections]]> Wed, 5 Sep 2007 07:15:00 +0200 http://cws.huginonline.com/N/134323/PR/200709/1151453_5.html Novartis International AG <![CDATA[Novartis completes divestment program with transfer of Gerber baby foods business]]> Mon, 3 Sep 2007 07:30:00 +0200 http://cws.huginonline.com/N/134323/PR/200709/1150584_5.html Novartis International AG <![CDATA[Study shows Rasilez®, the first and only approved direct renin inhibitor, reduces a marker of heart failure severity and is well-tolerated]]> Sun, 2 Sep 2007 11:00:00 +0200 http://cws.huginonline.com/N/134323/PR/200709/1150590_5.html Novartis International AG <![CDATA[Sandoz Receives European Commission Approval for biosimilar epoetin alfa]]> Fri, 31 Aug 2007 07:15:00 +0200 http://cws.huginonline.com/N/134323/PR/200708/1150279_5.html Novartis International AG <![CDATA[Novartis announces the retirement of Urs Baerlocher]]> Wed, 29 Aug 2007 07:15:00 +0200 http://cws.huginonline.com/N/134323/PR/200708/1149615_5.html Novartis International AG <![CDATA[Rasilez® receives EU approval, the first major innovation in high blood pressure treatment for more than a decade]]> Mon, 27 Aug 2007 07:15:00 +0200 http://cws.huginonline.com/N/134323/PR/200708/1149047_5.html Novartis International AG <![CDATA[Reclast® receives US regulatory approval as first and only once-yearly treatment for women with postmenopausal osteoporosis]]> Sat, 18 Aug 2007 00:00:00 +0200 http://cws.huginonline.com/N/134323/PR/200708/1147705_5.html Novartis International AG <![CDATA[Novartis starts US shipment of Fluvirin® allowing for early influenza vaccination of millions of Americans ]]> Thu, 16 Aug 2007 07:15:00 +0200 http://cws.huginonline.com/N/134323/PR/200708/1146984_5.html Novartis International AG <![CDATA[FDA grants additional six months marketing exclusivity for the high blood pressure medicine Diovan®]]> Fri, 10 Aug 2007 07:15:00 +0200 http://cws.huginonline.com/N/134323/PR/200708/1145530_5.html Novartis International AG <![CDATA[Novartis concerned Indian court ruling will discourage investments in innovation needed to bring better medicines to patients ]]> Mon, 6 Aug 2007 10:59:00 +0200 http://cws.huginonline.com/N/134323/PR/200708/1144199_5.html Novartis International AG <![CDATA[Tasigna® approved in Switzerland based on impressive efficacy in patients with a form of leukemia no longer responding to Glivec®]]> Wed, 25 Jul 2007 07:15:00 +0200 http://cws.huginonline.com/N/134323/PR/200707/1141673_5.html Novartis International AG <![CDATA[Novartis completes its fourth share repurchase program]]> Mon, 23 Jul 2007 14:45:00 +0200 http://cws.huginonline.com/N/134323/PR/200707/1141323_5.html Novartis International AG <![CDATA[New data show Tekturna® and Diovan® used together provide additive blood pressure reductions]]> Fri, 20 Jul 2007 01:02:00 +0200 http://cws.huginonline.com/N/134323/PR/200707/1140965_5.html Novartis International AG <![CDATA[Exelon® skin patch recommended for European approval, the first use of this new technology to treat patients with Alzheimer's disease]]> Thu, 19 Jul 2007 20:25:00 +0200 http://cws.huginonline.com/N/134323/PR/200707/1140963_5.html Novartis International AG <![CDATA[Aclasta® recommended for European approval as the first once-yearly treatment for women with postmenopausal osteoporosis]]> Thu, 19 Jul 2007 20:13:00 +0200 http://cws.huginonline.com/N/134323/PR/200707/1140962_5.html Novartis International AG <![CDATA[Galvus®, a new oral treatment for type 2 diabetes, receives positive opinion recommending European Union approval]]> Thu, 19 Jul 2007 20:13:00 +0200 http://cws.huginonline.com/N/134323/PR/200707/1140960_5.html Novartis International AG <![CDATA[Novartis delivers strong performance in first half of 2007 (H1 - Report)]]> Tue, 17 Jul 2007 07:00:00 +0200 http://cws.huginonline.com/N/134323/PR/200707/1140047_5.html Novartis International AG <![CDATA[Exelon®Patch, the first and only skin patch for the treatment of Alzheimer's disease, receives first worldwide approval in US]]> Mon, 9 Jul 2007 07:15:00 +0200 http://cws.huginonline.com/N/134323/PR/200707/1138163_5.html Novartis International AG <![CDATA[Novartis plans 30% increase in US supplies of Fluvirin® influenza vaccines and delivery of 40 million doses for 2007/2008 season ]]> Tue, 3 Jul 2007 07:15:00 +0200 http://cws.huginonline.com/N/134323/PR/200707/1137173_5.html Novartis International AG <![CDATA[Novartis completes divestment of Medical Nutrition business]]> Mon, 2 Jul 2007 07:30:00 +0200 http://cws.huginonline.com/N/134323/PR/200707/1136831_5.html Novartis International AG <![CDATA[Novartis enhances its vaccine pipeline by gaining access to Intercell's key technologies and vaccines programs]]> Mon, 2 Jul 2007 07:00:00 +0200 http://cws.huginonline.com/N/134323/PR/200707/1136830_5.html Novartis International AG <![CDATA[New data from multiple studies show Galvus® delivers consistent and robust blood sugar control in patients with type 2 diabetes]]> Mon, 25 Jun 2007 07:15:00 +0200 http://cws.huginonline.com/N/134323/PR/200706/1135162_5.html Novartis International AG <![CDATA[Sandoz receives positive EU opinion for approval of epoetin alfa biosimilar ]]> Fri, 22 Jun 2007 14:04:00 +0200 http://cws.huginonline.com/N/134323/PR/200706/1135070_5.html Novartis International AG <![CDATA[Rasilez®, an important new treatment for high blood pressure, receives positive opinion recommending European Union approval]]> Fri, 22 Jun 2007 14:03:00 +0200 http://cws.huginonline.com/N/134323/PR/200706/1135068_5.html Novartis International AG <![CDATA[Exforge® receives final US approval as new and powerful treatment option for patients with high blood pressure]]> Thu, 21 Jun 2007 07:15:00 +0200 http://cws.huginonline.com/N/134323/PR/200706/1134714_5.html Novartis International AG <![CDATA[Prexige® study shows significantly less impact on blood pressure than ibuprofen in osteoarthritis patients with controlled hypertension]]> Fri, 15 Jun 2007 07:15:00 +0200 http://cws.huginonline.com/N/134323/PR/200706/1133071_5.html Novartis International AG <![CDATA[Novartis gains European approval for its innovative flu vaccine Optaflu®]]> Wed, 13 Jun 2007 07:15:00 +0200 http://cws.huginonline.com/N/134323/PR/200706/1132639_5.html Novartis International AG <![CDATA[US court allows Teva to resume US sales of its generic version of Lotrel]]> Mon, 11 Jun 2007 20:06:00 +0200 http://cws.huginonline.com/N/134323/PR/200706/1132363_5.html Novartis International AG <![CDATA[Study shows one year of Glivec® reduces risk of cancer returning by 82% following surgery for gastrointestinal stromal tumors]]> Mon, 4 Jun 2007 08:00:00 +0200 http://cws.huginonline.com/N/134323/PR/200706/1132897_5.html Novartis International AG <![CDATA[US court continues to prevent Teva from shipping any additional generic copies of the high blood pressure medicine Lotrel]]> Tue, 29 May 2007 21:46:00 +0200 http://cws.huginonline.com/N/134323/PR/200705/1129631_5.html Novartis International AG <![CDATA[Exforge® helps vast majority of patients effectively control their blood pressure after failing on other medicines, according to new clinical data]]> Mon, 21 May 2007 07:15:00 +0200 http://cws.huginonline.com/N/134323/PR/200705/1127684_5.html Novartis International AG <![CDATA[Single-tablet combination of Tekturna® and diuretic, an important new option for people with high blood pressure, submitted for US approval]]> Mon, 21 May 2007 07:15:00 +0200 http://cws.huginonline.com/N/134323/PR/200705/1127682_5.html Novartis International AG <![CDATA[Focetria®, the Novartis pandemic influenza vaccine, receives European Union approval]]> Tue, 8 May 2007 07:15:00 +0200 http://cws.huginonline.com/N/134323/PR/200705/1124782_5.html Novartis International AG <![CDATA[Sebivo® approved in European Union as a new first-line treatment for chronic hepatitis B]]> Mon, 30 Apr 2007 09:08:00 +0200 http://cws.huginonline.com/N/134323/PR/200704/1122903_5.html Novartis International AG <![CDATA[Optaflu®, the Novartis cell culture-derived influenza vaccine, receives positive opinion supporting European Union regulatory approval]]> Fri, 27 Apr 2007 12:11:00 +0200 http://cws.huginonline.com/N/134323/PR/200704/1122731_5.html Novartis International AG <![CDATA[Diovan® achieved 40% reduction in stroke and cardiovascular events in landmark Jikei Heart Study]]> Fri, 27 Apr 2007 07:37:00 +0200 http://cws.huginonline.com/N/134323/PR/200704/1122583_5.html Novartis International AG <![CDATA[Over 10 000 Novartis associates worldwide take part in Community Partnership Day]]> Thu, 26 Apr 2007 07:30:00 +0200 http://cws.huginonline.com/N/134323/PR/200704/1121970_5.html Novartis International AG <![CDATA[Novartis delivers 4.7 million treatments of anti-malarial medicine to Tanzania on Africa Malaria Day]]> Wed, 25 Apr 2007 07:30:00 +0200 http://cws.huginonline.com/N/134323/PR/200704/1121463_5.html Novartis International AG <![CDATA[Novartis expands portfolio of respiratory medicines by acquiring rights to a novel therapeutic vaccine against nicotine addiction]]> Wed, 25 Apr 2007 07:15:00 +0200 http://cws.huginonline.com/N/134323/PR/200704/1121458_5.html Novartis International AG <![CDATA[Novartis with dynamic growth in the 2007 first quarter (Q1 - Media release)]]> Mon, 23 Apr 2007 07:00:00 +0200 http://cws.huginonline.com/N/134323/PR/200704/1120505_5.html Novartis International AG <![CDATA[Novartis with dynamic growth in the 2007 first quarter (Q1 - Report)]]> Mon, 23 Apr 2007 07:00:00 +0200 http://cws.huginonline.com/N/134323/PR/200704/1120500_5.html Novartis International AG <![CDATA[Novartis expands late-stage oncology pipeline with AS1404, a novel agent shown to break down blood vessels that support tumor growth]]> Thu, 19 Apr 2007 07:15:00 +0200 http://cws.huginonline.com/N/134323/PR/200704/1119817_5.html Novartis International AG <![CDATA[Reclast® receives US approval as a highly effective treatment for patients with Paget's disease of the bone]]> Tue, 17 Apr 2007 07:15:00 +0200 http://cws.huginonline.com/N/134323/PR/200704/1119023_5.html Novartis International AG <![CDATA[Positive results prompt US National Cancer Institute to make Glivec® available to patients in post-surgical GIST study]]> Thu, 12 Apr 2007 22:00:00 +0200 http://cws.huginonline.com/N/134323/PR/200704/1118349_5.html Novartis International AG <![CDATA[Novartis completes its business portfolio restructuring, divesting Gerber for USD 5.5 billion to Nestlé]]> Thu, 12 Apr 2007 07:29:00 +0200 http://cws.huginonline.com/N/134323/PR/200704/1118074_5.html Novartis International AG <![CDATA[Novartis suspends US marketing and sales of Zelnorm(R) in response to request from FDA]]> Fri, 30 Mar 2007 18:00:00 +0200 http://cws.huginonline.com/N/134323/PR/200703/1116336_5.html Novartis International AG <![CDATA[Tekturna®, first new type of high blood pressure medicine in a decade, provides additional blood pressure reduction when used with Diovan® ]]> Mon, 26 Mar 2007 16:39:00 +0200 http://cws.huginonline.com/N/134323/PR/200703/1114292_5.html Novartis International AG <![CDATA[Novartis to launch its own branded version of a leading multiple sclerosis therapy through agreement with Bayer Schering Pharma]]> Mon, 26 Mar 2007 07:15:00 +0200 http://cws.huginonline.com/N/134323/PR/200703/1114185_5.html Novartis International AG <![CDATA[Novartis ranked No. 1 among pharmaceutical companies in Fortune magazine's ''World's Most Admired Companies'' survey]]> Tue, 13 Mar 2007 14:05:00 +0100 http://cws.huginonline.com/N/134323/PR/200703/1111387_5.html Novartis International AG <![CDATA[Novartis shareholders approve all resolutions at 2007 Annual General Meeting, including dividend increase and Board elections]]> Tue, 6 Mar 2007 15:28:00 +0100 http://cws.huginonline.com/N/134323/PR/200703/1109992_5.html Novartis International AG <![CDATA[Tekturna® - the first new type of high blood pressure medicine in more than a decade - receives its first approval in the US]]> Tue, 6 Mar 2007 07:15:00 +0100 http://cws.huginonline.com/N/134323/PR/200703/1109749_5.html Novartis International AG <![CDATA[Novartis to market newly approved Procleix® Tigris® System in U.S. as the first fully automated system for West Nile virus blood screening]]> Sat, 3 Mar 2007 01:10:00 +0100 http://cws.huginonline.com/N/134323/PR/200703/1109430_5.html Novartis International AG <![CDATA[Sebivo® approved in China for treatment of chronic hepatitis B, the nation's second leading cause of death]]> Fri, 2 Mar 2007 07:15:00 +0100 http://cws.huginonline.com/N/134323/PR/200703/1109135_5.html Novartis International AG <![CDATA[Leading proxy advisory firm ISS recommends Novartis shareholders to approve all Board proposals at next Annual General Meeting]]> Mon, 26 Feb 2007 07:30:00 +0100 http://cws.huginonline.com/N/134323/PR/200702/1107681_5.html Novartis International AG <![CDATA[Novartis committed to making Galvus® available for patients with type 2 diabetes after US regulators issue ''approvable letter'']]> Mon, 26 Feb 2007 07:15:00 +0100 http://cws.huginonline.com/N/134323/PR/200702/1107676_5.html Novartis International AG <![CDATA[Focetria® pandemic influenza vaccine receives positive European Union regulatory agency opinion supporting approval]]> Fri, 23 Feb 2007 12:33:00 +0100 http://cws.huginonline.com/N/134323/PR/200702/1107525_5.html Novartis International AG <![CDATA[Novartis seeking clarity in Indian patent laws, a critical incentive for long-term R&D investments into better medicines for patients]]> Thu, 15 Feb 2007 10:04:00 +0100 http://cws.huginonline.com/N/134323/PR/200702/1105441_5.html Novartis International AG <![CDATA[Novartis, The Broad Institute, and Lund University announce release of genome-wide analysis of genes associated with type 2 diabetes and related metabolic disorders]]> Mon, 12 Feb 2007 17:30:00 +0100 http://cws.huginonline.com/N/134323/PR/200702/1104411_5.html Novartis International AG <![CDATA[Novartis proposes approval of tenth consecutive higher dividend payment and election of new Board member at Annual General Meeting]]> Fri, 9 Feb 2007 07:15:00 +0100 http://cws.huginonline.com/N/134323/PR/200702/1103588_5.html Novartis International AG <![CDATA[Novartis files 2006 annual report on Form 20-Fwith the US Securities and Exchange Commission]]> Thu, 1 Feb 2007 20:28:35 +0100 http://cws.huginonline.com/N/134323/PR/200702/1101642_5.html Novartis International AG <![CDATA[Novartis Institute for Tropical Diseases inaugurates new Indonesian research initiative to study dengue fever, tuberculosis and malaria]]> Thu, 25 Jan 2007 08:00:00 +0100 http://cws.huginonline.com/N/134323/PR/200701/1099769_5.html Novartis International AG <![CDATA[Lucentis® receives approval in the European Union - the first drug to improve vision in patients with wet AMD, a leading cause of blindness]]> Wed, 24 Jan 2007 07:15:00 +0100 http://cws.huginonline.com/N/134323/PR/200701/1099600_5.html Novartis International AG <![CDATA[Exforge® approved in Europe as powerful new blood pressure therapy combining two leading medications in a single pill]]> Thu, 18 Jan 2007 07:00:00 +0100 http://cws.huginonline.com/N/134323/PR/200701/1098758_5.html Novartis International AG <![CDATA[Novartis strategic healthcare portfolio drives sustained strong performance with record full-year results in 2006]]> Thu, 18 Jan 2007 07:00:00 +0100 http://cws.huginonline.com/N/134323/PR/200701/1098754_5.html Novartis International AG <![CDATA[Novartis receives US government contract to further develop a novel antigen technology that could extend vaccine supplies in a pandemic outbreak]]> Wed, 17 Jan 2007 17:30:00 +0100 http://cws.huginonline.com/N/134323/PR/200701/1098644_5.html Novartis International AG <![CDATA[Exforge® receives US regulatory approval as a new and highly effective treatment option for patients with high blood pressure]]> Fri, 22 Dec 2006 07:15:00 +0100 http://cws.huginonline.com/N/134323/PR/200612/1094960_5.html Novartis International AG <![CDATA[Novartis making significant progress in creating new strategic growth platform in human vaccines, names site for new division headquarters]]> Thu, 14 Dec 2006 22:00:00 +0100 http://cws.huginonline.com/N/134323/PR/200612/1093411_5.html Novartis International AG <![CDATA[Novartis to further focus on healthcare, reaching agreement to sell its Medical Nutrition business ]]> Thu, 14 Dec 2006 07:30:00 +0100 http://cws.huginonline.com/N/134323/PR/200612/1093243_5.html Novartis International AG <![CDATA[Novartis announces three-month extension of US regulatory review period for Tekturna®]]> Thu, 14 Dec 2006 07:15:00 +0100 http://cws.huginonline.com/N/134323/PR/200612/1093232_5.html Novartis International AG <![CDATA[Pivotal submission data shows Tasigna® achieved impressive response rates in chronic myeloid leukemia patients no longer helped by Glivec®]]> Mon, 11 Dec 2006 14:00:00 +0100 http://cws.huginonline.com/N/134323/PR/200612/1092474_5.html Novartis International AG <![CDATA[Glivec® demonstrates highest five-year overall survival rate in history of treatment for patients with chronic myeloid leukemia]]> Wed, 6 Dec 2006 23:00:00 +0100 http://cws.huginonline.com/N/134323/PR/200612/1091864_5.html Novartis International AG <![CDATA[New evidence reinforces efficacy and tolerability of Galvus® as a new once-daily oral treatment option for patients with type 2 diabetes]]> Wed, 6 Dec 2006 07:15:00 +0100 http://cws.huginonline.com/N/134323/PR/200612/1091731_5.html Novartis International AG <![CDATA[Novartis highlights strong R&D pipeline, plans for multiple new product launches and novel projects moving into late-stage trials]]> Tue, 28 Nov 2006 07:15:00 +0100 http://cws.huginonline.com/N/134323/PR/200611/1090332_5.html Novartis International AG <![CDATA[Novartis secures contract to supply additional H5N1 influenza vaccine to the US government]]> Mon, 20 Nov 2006 18:05:00 +0100 http://cws.huginonline.com/N/134323/PR/200611/1089243_5.html Novartis International AG <![CDATA[Novartis to provide additional clarification to EU regulators on data supporting approval of Mycograb® for serious fungal infections]]> Fri, 17 Nov 2006 15:03:46 +0100 http://cws.huginonline.com/N/134323/PR/200611/1088976_5.html Novartis International AG <![CDATA[Lucentis® receives positive European Union regulatory agency opinion for approval as new treatment for a leading cause of severe vision loss ]]> Fri, 17 Nov 2006 15:02:47 +0100 http://cws.huginonline.com/N/134323/PR/200611/1088975_5.html Novartis International AG <![CDATA[Exforge® receives positive European Union regulatory opinion supporting approval as effective new treatment for patients with high blood pressure]]> Fri, 17 Nov 2006 15:01:05 +0100 http://cws.huginonline.com/N/134323/PR/200611/1088974_5.html Novartis International AG <![CDATA[Novartis announces three-month extension of US regulatory review for Galvus® to assess recently available clinical data]]> Mon, 13 Nov 2006 07:15:00 +0100 http://cws.huginonline.com/N/134323/PR/200611/1087811_5.html Novartis International AG <![CDATA[Prexige® cleared for approval in the European Union as a new treatment option for patients suffering from osteoarthritic pain]]> Tue, 7 Nov 2006 07:15:00 +0100 http://cws.huginonline.com/N/134323/PR/200611/1086395_5.html Novartis International AG <![CDATA[Novartis creates new strategic biomedical R&D center in Shanghai]]> Mon, 6 Nov 2006 05:00:00 +0100 http://cws.huginonline.com/N/134323/PR/200611/1086199_5.html Novartis International AG <![CDATA[Tyzeka(TM) receives US regulatory approval as a new treatment for patients with chronic hepatitis B]]> Wed, 25 Oct 2006 21:30:00 +0200 http://cws.huginonline.com/N/134323/PR/200610/1083687_5.html Novartis International AG <![CDATA[New Zelnorm® data demonstrate relief of multiple symptoms of dysmotility-type dyspepsia]]> Mon, 23 Oct 2006 14:30:00 +0200 http://cws.huginonline.com/N/134323/PR/200610/1082758_5.html Novartis International AG <![CDATA[Glivec® approved in the US for five rare life-threatening disorders with limited treatment options]]> Fri, 20 Oct 2006 01:01:40 +0200 http://cws.huginonline.com/N/134323/PR/200610/1082376_5.html Novartis International AG <![CDATA[Novartis Animal Health expands presence in Japan with acquisition]]> Thu, 19 Oct 2006 08:30:00 +0200 http://cws.huginonline.com/N/134323/PR/200610/1082013_5.html Novartis International AG <![CDATA[Pivotal Phase III trial results show Novartis cell culture-derived influenza vaccine well tolerated and efficacious]]> Thu, 19 Oct 2006 07:15:00 +0200 http://cws.huginonline.com/N/134323/PR/200610/1082056_5.html Novartis International AG <![CDATA[Novartis delivers dynamic sales and earnings growth in the first nine months of 2006, reaffirms outlook for record full-year results]]> Thu, 19 Oct 2006 07:00:00 +0200 http://cws.huginonline.com/N/134323/PR/200610/1082045_5.html Novartis International AG <![CDATA[Novartis launches ''GALIANT'' study comparing the investigational drug Galvus® and a leading class of oral anti-diabetic medicines]]> Wed, 11 Oct 2006 17:00:00 +0200 http://cws.huginonline.com/N/134323/PR/200610/1080656_5.html Novartis International AG <![CDATA[Lucentis shows significant vision benefits in pivotal Phase III data published in New England Journal of Medicine]]> Wed, 4 Oct 2006 23:00:00 +0200 http://cws.huginonline.com/N/134323/PR/200610/1079164_5.html Novartis International AG <![CDATA[New four-year results of major trial confirm Femara® significantly cuts risk of breast cancer recurrence and spread after surgery]]> Mon, 2 Oct 2006 15:45:00 +0200 http://cws.huginonline.com/N/134323/PR/200610/1078903_5.html Novartis International AG <![CDATA[Novartis announces initiative to improve access to state-of-the-art anti-malarial treatment Coartem®]]> Fri, 29 Sep 2006 07:15:00 +0200 http://cws.huginonline.com/N/134323/PR/200609/1078440_5.html Novartis International AG <![CDATA[Novartis seeks European approval for Rasilez® to become the first in a new class of medicines to help patients with high blood pressure]]> Thu, 28 Sep 2006 07:15:00 +0200 http://cws.huginonline.com/N/134323/PR/200609/1078132_5.html Novartis International AG <![CDATA[New data for FTY720 - aiming to become the first orally effective multiple sclerosis treatment - show sustained benefits over two years]]> Thu, 28 Sep 2006 07:15:00 +0200 http://cws.huginonline.com/N/134323/PR/200609/1077940_5.html Novartis International AG <![CDATA[First-in-class asthma therapy Xolair® wins prestigious Prix Galien award for outstanding innovation in research and development ]]> Wed, 27 Sep 2006 16:43:00 +0200 http://cws.huginonline.com/N/134323/PR/200609/1078075_5.html Novartis International AG <![CDATA[Sebivo® receives first major approval in Switzerland as new treatment for patients with chronic hepatitis B]]> Thu, 21 Sep 2006 07:15:00 +0200 http://cws.huginonline.com/N/134323/PR/200609/1076869_5.html Novartis International AG <![CDATA[Glivec® receives additional EU approvals for use in treating a rapidly progressive form of leukemia and a hard-to-treat solid cancer tumor]]> Tue, 19 Sep 2006 07:15:00 +0200 http://cws.huginonline.com/N/134323/PR/200609/1075826_5.html Novartis International AG <![CDATA[New data demonstrate benefits of once-yearly Aclasta® in the treatment of postmenopausal osteoporosis]]> Sat, 16 Sep 2006 22:45:00 +0200 http://cws.huginonline.com/N/134323/PR/200609/1075407_5.html Novartis International AG <![CDATA[Galvus® demonstrates powerful blood sugar reductions in Phase III studies without the side effects associated with many anti-diabetic drugs]]> Thu, 14 Sep 2006 07:15:00 +0200 http://cws.huginonline.com/N/134323/PR/200609/1075250_5.html Novartis International AG <![CDATA[FTY720 shows significant benefits in helping MS patients over one year in Phase II data published in New England Journal of Medicine]]> Wed, 13 Sep 2006 23:00:00 +0200 http://cws.huginonline.com/N/134323/PR/200609/1075246_5.html Novartis International AG <![CDATA[New Rasilez® data highlight potential of direct renin inhibition to control blood pressure over long-term without risk of rebound[1]]]> Sun, 3 Sep 2006 08:30:00 +0200 http://cws.huginonline.com/N/134323/PR/200609/1072840_5.html Novartis International AG <![CDATA[Exjade®, a breakthrough for patients with transfusional iron overload, gains European Union approval]]> Wed, 30 Aug 2006 07:15:00 +0200 http://cws.huginonline.com/N/134323/PR/200608/1072209_5.html Novartis International AG <![CDATA[First European approval in Switzerland for Lucentis® as a breakthrough treatment for a leading cause of blindness in people over age 50]]> Tue, 29 Aug 2006 07:15:00 +0200 http://cws.huginonline.com/N/134323/PR/200608/1071973_5.html Novartis International AG <![CDATA[Novartis seeks European approval for Galvus®, an innovative oral treatment for people with type 2 diabetes ]]> Thu, 17 Aug 2006 07:15:00 +0200 http://cws.huginonline.com/N/134323/PR/200608/1069550_5.html Novartis International AG <![CDATA[Novartis releases Fluvirin® influenza virus vaccine to US distributors]]> Wed, 16 Aug 2006 07:15:00 +0200 http://cws.huginonline.com/N/134323/PR/200608/1069333_5.html Novartis International AG <![CDATA[Novartis and Schering-Plough announce collaboration to develop novel once-daily combination therapy for asthma and COPD]]> Mon, 14 Aug 2006 07:15:00 +0200 http://cws.huginonline.com/N/134323/PR/200608/1068858_5.html Novartis International AG <![CDATA[Novartis MeNZB(TM) vaccine campaign data show 80 percent efficacy rate during epidemic meningococcal B disease outbreak in New Zealand ]]> Tue, 8 Aug 2006 07:00:00 +0200 http://cws.huginonline.com/N/134323/PR/200608/1068580_5.html Novartis International AG <![CDATA[Glivec® receives positive European Union opinion for treatment of rare, potentially life-threatening cancers with limited treatment options]]> Fri, 28 Jul 2006 16:14:23 +0200 http://cws.huginonline.com/N/134323/PR/200607/1066400_5.html Novartis International AG <![CDATA[Sandoz signs exclusive collaboration with Momenta Pharmaceuticals to develop complex generics and follow-on biotechnology drugs]]> Tue, 25 Jul 2006 16:00:50 +0200 http://cws.huginonline.com/N/134323/PR/200607/1065640_5.html Novartis International AG <![CDATA[Study shows Neoral® provides kidney transplant patients with efficacy equivalent to tacrolimus and significantly lower incidence of diabetes ]]> Mon, 24 Jul 2006 18:00:05 +0200 http://cws.huginonline.com/N/134323/PR/200607/1065489_5.html Novartis International AG <![CDATA[Exelon Patch, the first transdermal therapy for Alzheimer's disease, may provide promising new approach to treatment of dementia]]> Wed, 19 Jul 2006 16:00:00 +0200 http://cws.huginonline.com/N/134323/PR/200607/1064533_5.html Novartis International AG <![CDATA[Novartis to build latest-technology influenza vaccines manufacturing site in North Carolina]]> Tue, 18 Jul 2006 14:00:00 +0200 http://cws.huginonline.com/N/134323/PR/200607/1064656_5.html Novartis International AG <![CDATA[Novartis generates strong sales and earnings growth in the first six months of 2006, growing faster than the world pharmaceuticals market]]> Mon, 17 Jul 2006 07:01:52 +0200 http://cws.huginonline.com/N/134323/PR/200607/1064053_5.html Novartis International AG <![CDATA[Novartis declares cash offer for NeuTec Pharma wholly unconditional ]]> Fri, 14 Jul 2006 08:00:00 +0200 http://cws.huginonline.com/N/134323/PR/200607/1063796_5.html Novartis International AG <![CDATA[Novartis passes 50% acceptance threshold in offer for NeuTec Pharma]]> Mon, 3 Jul 2006 12:16:03 +0200 http://cws.huginonline.com/N/134323/PR/200607/1061565_5.html Novartis International AG <![CDATA[Novartis submits Xolair® for approval in Japan as first-in-class treatment for severe asthma]]> Mon, 26 Jun 2006 07:15:00 +0200 http://cws.huginonline.com/N/134323/PR/200606/1059811_5.html Novartis International AG <![CDATA[Patients with treatment-resistant leukemia achieve high responses to Tasigna® (nilotinib) in first published clinical trial results]]> Wed, 14 Jun 2006 23:00:00 +0200 http://cws.huginonline.com/N/134323/PR/200606/1056533_5.html Novartis International AG <![CDATA[Novartis unveils further impressive efficacy data for the investigational oral diabetes compound Galvus® showing significant blood sugar reductions]]> Tue, 13 Jun 2006 14:30:00 +0200 http://cws.huginonline.com/N/134323/PR/200606/1056044_5.html Novartis International AG <![CDATA[Rasilez® shows superior efficacy to ACE inhibitor ramipril in head-to-head study involving people with diabetes and high blood pressure]]> Tue, 13 Jun 2006 07:15:00 +0200 http://cws.huginonline.com/N/134323/PR/200606/1055692_5.html Novartis International AG <![CDATA[Novartis expands late-stage vaccines pipeline with novel vaccine for prevention of Japanese Encephalitis virus infections]]> Tue, 13 Jun 2006 07:00:00 +0200 http://cws.huginonline.com/N/134323/PR/200606/1056015_5.html Novartis International AG <![CDATA[Novartis makes offer for NeuTec Pharma, acquisition adds two highly promising biotech drugs to portfolio for patients with severe infections]]> Wed, 7 Jun 2006 07:15:00 +0200 http://cws.huginonline.com/N/134323/PR/200606/1054269_5.html Novartis International AG <![CDATA[Novartis strengthens infectious disease portfolio by acquiring rights to Albuferon(TM), a hepatitis C interferon drug set to enter Phase III trials]]> Tue, 6 Jun 2006 07:15:00 +0200 http://cws.huginonline.com/N/134323/PR/200606/1054087_5.html Novartis International AG <![CDATA[Novartis launches global program expanding access to investigational compound nilotinib (AMN107) for patients with hard-to-treat leukemia]]> Sun, 4 Jun 2006 23:00:00 +0200 http://cws.huginonline.com/N/134323/PR/200606/1054010_5.html Novartis International AG <![CDATA[Glivec® sets new treatment standard in chronic myeloid leukemia with high overall survival, increasing response and decreasing progression]]> Sat, 3 Jun 2006 22:00:00 +0200 http://cws.huginonline.com/N/134323/PR/200606/1053996_5.html Novartis International AG <![CDATA[Sandoz gets precedent-setting US approval for Omnitrope® as first follow-on version of a previously approved recombinant biotechnology drug]]> Wed, 31 May 2006 10:30:36 +0200 http://cws.huginonline.com/N/134323/PR/200605/1053382_5.html Novartis International AG <![CDATA[Novartis spearheads innovative malaria research project in newly created public-private partnership]]> Tue, 23 May 2006 10:15:00 +0200 http://cws.huginonline.com/N/134323/PR/200605/1052419_5.html Novartis International AG <![CDATA[Diovan® the first blood pressure medication in a large-scale clinical trial to lower C-reactive protein, an important marker of inflammation]]> Fri, 19 May 2006 07:15:00 +0200 http://cws.huginonline.com/N/134323/PR/200605/1051807_5.html Novartis International AG <![CDATA[Novartis announces first Phase III Exforge data, shows strong efficacy as new high blood pressure treatment with dual mechanisms of action]]> Wed, 17 May 2006 07:15:00 +0200 http://cws.huginonline.com/N/134323/PR/200605/1051497_5.html Novartis International AG <![CDATA[New data demonstrates efficacy of Rasilez as a potentially innovative oral direct renin inhibitor for treatment of high blood pressure]]> Wed, 17 May 2006 07:15:00 +0200 http://cws.huginonline.com/N/134323/PR/200605/1051483_5.html Novartis International AG <![CDATA[Five years after approval, Glivec underscores the promise of targeted therapy to provide sustained disease control]]> Wed, 10 May 2006 07:15:00 +0200 http://cws.huginonline.com/N/134323/PR/200605/1050165_5.html Novartis International AG <![CDATA[Novartis awarded up to USD 220 million by US Department of Health and Human Services for development of cell culture-derived influenza vaccine]]> Thu, 4 May 2006 16:00:51 +0200 http://cws.huginonline.com/N/134323/PR/200605/1049147_5.html Novartis International AG <![CDATA[US submission of Exforge® accepted for review by the FDA as a new therapy option for high blood pressure]]> Thu, 27 Apr 2006 07:15:00 +0200 http://cws.huginonline.com/N/134323/PR/200604/1047147_5.html Novartis International AG <![CDATA[Novartis delivers strong start to 2006 in first quarter with excellent sales and earnings growth performance]]> Mon, 24 Apr 2006 07:01:00 +0200 http://cws.huginonline.com/N/134323/PR/200604/1046164_5.html Novartis International AG <![CDATA[New drug application for Rasilez®, an innovative oral renin inhibitor to treat high blood pressure, accepted for US regulatory review]]> Thu, 20 Apr 2006 07:15:00 +0200 http://cws.huginonline.com/N/134323/PR/200604/1045693_5.html Novartis International AG <![CDATA[Novartis acquisition of Chiron approved by Chiron shareholders]]> Wed, 19 Apr 2006 18:28:38 +0200 http://cws.huginonline.com/N/134323/PR/200604/1045686_5.html Novartis International AG <![CDATA[Sandoz Receives European Commission Marketing Authorization for Omnitrope®]]> Tue, 18 Apr 2006 14:00:00 +0200 http://cws.huginonline.com/N/134323/PR/200604/1045355_5.html Novartis International AG <![CDATA[Novartis completes submissions in US and Europe for Glivec® as treatment for four rare types of cancer]]> Mon, 10 Apr 2006 07:15:00 +0200 http://cws.huginonline.com/N/134323/PR/200604/1044420_5.html Novartis International AG <![CDATA[Phase II data for FTY720 shows sustained efficacy and good tolerability over 18 months in patients with relapsing multiple sclerosis (MS)]]> Thu, 6 Apr 2006 07:15:00 +0200 http://cws.huginonline.com/N/134323/PR/200604/1043685_5.html Novartis International AG <![CDATA[Novartis and Chiron amend merger agreement, required shareholder approval now virtually assured]]> Mon, 3 Apr 2006 18:20:20 +0200 http://cws.huginonline.com/N/134323/PR/200604/1042977_5.html Novartis International AG <![CDATA[New drug application for Galvus®, an innovative oral therapy for people with type 2 diabetes, accepted for review by FDA]]> Thu, 30 Mar 2006 07:15:00 +0200 http://cws.huginonline.com/N/134323/PR/200603/1041987_5.html Novartis International AG <![CDATA[Novartis announces in-licensing of valopicitabine (NM283), a novel first-in-class treatment for hepatitis C that expands infectious diseases portfolio]]> Wed, 29 Mar 2006 07:15:00 +0200 http://cws.huginonline.com/N/134323/PR/200603/1041772_5.html Novartis International AG <![CDATA[Novartis and Servier sign licensing agreement for a novel treatment of Major Depressive Disorder]]> Wed, 29 Mar 2006 07:15:00 +0200 http://cws.huginonline.com/N/134323/PR/200603/1041770_5.html Novartis International AG <![CDATA[New data show telbivudine superior to lamivudine in treatment of Chinese patients with chronic hepatitis B]]> Mon, 27 Mar 2006 07:15:00 +0200 http://cws.huginonline.com/N/134323/PR/200603/1041252_5.html Novartis International AG <![CDATA[Novartis provides update on regulatory status of Zelnorm® in Europe]]> Fri, 24 Mar 2006 17:30:00 +0100 http://cws.huginonline.com/N/134323/PR/200603/1041002_5.html Novartis International AG <![CDATA[Femara® approved in Germany as initial therapy for postmenopausal women with early breast cancer after surgery]]> Mon, 20 Mar 2006 07:15:00 +0100 http://cws.huginonline.com/N/134323/PR/200603/1039925_5.html Novartis International AG <![CDATA[Aclasta® may offer a new approach for improving bone health]]> Thu, 16 Mar 2006 12:00:00 +0100 http://cws.huginonline.com/N/134323/PR/200603/1039829_5.html Novartis International AG <![CDATA[Exelon® granted EU marketing authorization as first treatment for dementia associated with Parkinson's disease by European Commission]]> Tue, 14 Mar 2006 15:34:39 +0100 http://cws.huginonline.com/N/134323/PR/200603/1039161_5.html Novartis International AG <![CDATA[Novartis seeks EU approval for Exforge®, a powerful combination of two leading blood pressure medicines in a convenient once-daily tablet]]> Fri, 3 Mar 2006 07:15:00 +0100 http://cws.huginonline.com/N/134323/PR/200603/1037376_5.html Novartis International AG <![CDATA[Novartis seeks European approval of Lucentis® for the treatment of patients with wet age-related macular degeneration (AMD)]]> Thu, 2 Mar 2006 07:24:42 +0100 http://cws.huginonline.com/N/134323/PR/200603/1037374_5.html Novartis International AG <![CDATA[Novartis shareholders approve ninth consecutive higher dividend payment at 2005 Annual General Meeting]]> Tue, 28 Feb 2006 15:21:14 +0100 http://cws.huginonline.com/N/134323/PR/200602/1037104_5.html Novartis International AG <![CDATA[Novartis receives ''approvable letter'' from the FDA for zoledronic acid 5 mg in the treatment of Paget's disease of the bone]]> Fri, 24 Feb 2006 22:35:00 +0100 http://cws.huginonline.com/N/134323/PR/200602/1036635_5.html Novartis International AG <![CDATA[Novartis and Alnylam announce new collaboration to develop RNAi therapeutics for pandemic flu]]> Tue, 21 Feb 2006 07:30:00 +0100 http://cws.huginonline.com/N/134323/PR/200602/1035836_5.html Novartis International AG <![CDATA[Novartis completes divestment of Nutrition & Santé unit]]> Fri, 17 Feb 2006 17:30:00 +0100 http://cws.huginonline.com/N/134323/PR/200602/1035622_5.html Novartis International AG <![CDATA[Novartis and Idenix seek European approval of telbivudine (LDT600) for the treatment of patients with chronic hepatitis B]]> Tue, 7 Feb 2006 07:15:00 +0100 http://cws.huginonline.com/N/134323/PR/200602/1033079_5.html Novartis International AG <![CDATA[Novartis receives European Commission approval to acquire Chiron]]> Mon, 6 Feb 2006 18:09:08 +0100 http://cws.huginonline.com/N/134323/PR/200602/1033141_5.html Novartis International AG <![CDATA[Novartis proposes higher dividend payment for 2005 and changes to Board of Directors for approval at next Annual General Meeting]]> Fri, 3 Feb 2006 07:45:00 +0100 http://cws.huginonline.com/N/134323/PR/200602/1032781_5.html Novartis International AG <![CDATA[CHMP adopts positive opinion recommending approval of Exelon® as first symptomatic treatment of mild to moderately severe dementia associated with idiopathic Parkinson's disease in the EU]]> Mon, 30 Jan 2006 07:30:00 +0100 http://cws.huginonline.com/N/134323/PR/200601/1031793_5.html Novartis International AG <![CDATA[Sandoz Welcomes CHMP Positive Opinion on Omnitrope]]> Fri, 27 Jan 2006 12:57:02 +0100 http://cws.huginonline.com/N/134323/PR/200601/1031718_5.html Novartis International AG <![CDATA[Novartis delivers strong performance with record results in 2005]]> Thu, 19 Jan 2006 07:09:00 +0100 http://cws.huginonline.com/N/134323/PR/200601/1030490_5.html Novartis International AG <![CDATA[Novartis accelerates production of life-saving malaria treatment Coartem®]]> Wed, 18 Jan 2006 15:00:00 +0100 http://cws.huginonline.com/N/134323/PR/200601/1030389_5.html Novartis International AG <![CDATA[Novartis Venture Fund to expand role in 2006 in supporting pharmaceutical start-up companies]]> Mon, 16 Jan 2006 16:00:00 +0100 http://cws.huginonline.com/N/134323/PR/200601/1030092_5.html Novartis International AG <![CDATA[Novartis decides not to make offer to acquire Berna Biotech]]> Tue, 10 Jan 2006 07:30:00 +0100 http://cws.huginonline.com/N/134323/PR/200601/1029300_5.html Novartis International AG <![CDATA[Idenix and Novartis announce new drug application submitted to the U.S. Food and Drug Administration for Telbivudine for the treatment of chronic hepatitis B]]> Tue, 3 Jan 2006 14:00:00 +0100 http://cws.huginonline.com/N/134323/PR/200601/1028538_5.html Novartis International AG <![CDATA[Femara® approved in the US as initial therapy for postmenopausal women with early breast cancer after surgery]]> Mon, 2 Jan 2006 16:20:00 +0100 http://cws.huginonline.com/N/134323/PR/200601/1028416_5.html Novartis International AG <![CDATA[Novartis reaffirms commitment to completing Chiron transaction on terms of existing merger agreement]]> Wed, 21 Dec 2005 07:30:00 +0100 http://cws.huginonline.com/N/134323/PR/200512/1026889_5.html Novartis International AG <![CDATA[Novartis to consider benefits of acquiring Berna Biotech]]> Sun, 18 Dec 2005 21:37:51 +0100 http://cws.huginonline.com/N/134323/PR/200512/1026292_5.html Novartis International AG <![CDATA[Novartis provides update on development status of NKS104]]> Fri, 16 Dec 2005 07:30:00 +0100 http://cws.huginonline.com/N/134323/PR/200512/1025912_5.html Novartis International AG <![CDATA[Novartis remains committed to making Zelnorm® available for women with irritable bowel syndrome with constipation in Europe]]> Thu, 15 Dec 2005 12:05:46 +0100 http://cws.huginonline.com/N/134323/PR/200512/1025752_5.html Novartis International AG <![CDATA[New clinical data shows dramatic benefits of Femara® for women with breast cancer even after prolonged period of no anti-cancer treatment]]> Tue, 13 Dec 2005 07:30:00 +0100 http://cws.huginonline.com/N/134323/PR/200512/1025081_5.html Novartis International AG <![CDATA[Glivec® seeking to become first targeted treatment for adult patients with a form of acute lymphoblastic leukemia]]> Tue, 13 Dec 2005 07:30:00 +0100 http://cws.huginonline.com/N/134323/PR/200512/1025079_5.html Novartis International AG <![CDATA[More than 90% of patients taking Glivec® for a form of chronic myeloid leukemia (CML) alive after 4-1/2 years in landmark study]]> Mon, 12 Dec 2005 14:15:00 +0100 http://cws.huginonline.com/N/134323/PR/200512/1025134_5.html Novartis International AG <![CDATA[Novartis employees honored with energy excellence awards]]> Thu, 8 Dec 2005 16:00:00 +0100 http://cws.huginonline.com/N/134323/PR/200512/1024699_5.html Novartis International AG <![CDATA[Novartis receives US regulatory approval to acquire Chiron]]> Tue, 6 Dec 2005 18:00:00 +0100 http://cws.huginonline.com/N/134323/PR/200512/1024431_5.html Novartis International AG <![CDATA[Novartis and Astex Therapeutics form global licensing and drug discovery alliance to focus on developing novel cell cycle cancer drugs]]> Tue, 6 Dec 2005 07:30:00 +0100 http://cws.huginonline.com/N/134323/PR/200512/1024307_5.html Novartis International AG <![CDATA[Novartis announces the successful divestment of its Nutrition & Santé unit]]> Mon, 28 Nov 2005 07:30:00 +0100 http://cws.huginonline.com/N/134323/PR/200511/1023055_5.html Novartis International AG <![CDATA[GLOBE study finds telbivudine superior to current standard of care on antiviral measures in patients with chronic hepatitis B]]> Mon, 14 Nov 2005 07:30:00 +0100 http://cws.huginonline.com/N/134323/PR/200511/1020875_5.html Novartis International AG <![CDATA[Novartis reaches agreement to develop and commercialize glaucoma treatment with novel mechanism of action]]> Wed, 9 Nov 2005 07:30:00 +0100 http://cws.huginonline.com/N/134323/PR/200511/1020088_5.html Novartis International AG <![CDATA[Preliminary data from second pivotal Phase III study showed Lucentis® maintained or improved vision in 95 percent of patients with age-related macular degeneration (AMD).]]> Mon, 7 Nov 2005 22:15:00 +0100 http://cws.huginonline.com/N/134323/PR/200511/1019970_5.html Novartis International AG <![CDATA[Exjade®, a breakthrough once-daily oral iron chelator, receives first approval worldwide in the US]]> Thu, 3 Nov 2005 08:30:00 +0100 http://cws.huginonline.com/N/134323/PR/200511/1019429_5.html Novartis International AG <![CDATA[Novartis announces leadership of new vaccines and diagnostics business]]> Thu, 3 Nov 2005 07:58:06 +0100 http://cws.huginonline.com/N/134323/PR/200511/1019451_5.html Novartis International AG <![CDATA[Novartis announces agreement to acquire remaining stake in Chiron]]> Mon, 31 Oct 2005 10:45:00 +0100 http://cws.huginonline.com/N/134323/PR/200510/1018774_5.html Novartis International AG <![CDATA[Xolair® granted marketing authorization in Europe as novel therapy for severe allergic asthma]]> Thu, 27 Oct 2005 07:30:00 +0200 http://cws.huginonline.com/N/134323/PR/200510/1018069_5.html Novartis International AG <![CDATA[Study shows conversion to Myfortic® from current therapy significantly improved quality of life for kidney transplant patients]]> Wed, 19 Oct 2005 07:30:00 +0200 http://cws.huginonline.com/N/134323/PR/200510/1016599_5.html Novartis International AG <![CDATA[Novartis delivers strong growth in first nine months of 2005, on track to achieve full-year sales and earnings objectives]]> Tue, 18 Oct 2005 11:23:36 +0200 http://cws.huginonline.com/N/134323/PR/200510/1016467_5.html Novartis International AG <![CDATA[World experts convene in Tanzania to address tuberculosis (TB) emergency]]> Mon, 17 Oct 2005 07:15:00 +0200 http://cws.huginonline.com/N/134323/PR/200510/1016482_5.html Novartis International AG <![CDATA[New research shows benefits of Elidel® in eczema patients who require an alternative to conventional steroid treatment]]> Fri, 14 Oct 2005 07:30:00 +0200 http://cws.huginonline.com/N/134323/PR/200510/1015473_5.html Novartis International AG <![CDATA[FTY720 Phase II 12-month data show sustained benefits and good tolerability in patients with relapsing multiple sclerosis]]> Sat, 1 Oct 2005 08:45:00 +0200 http://cws.huginonline.com/N/134323/PR/200510/1013921_5.html Novartis International AG <![CDATA[FDA advisory committee votes unanimously to recommend approval of Exjade® for once-daily oral treatment of chronic iron overload due to blood transfusions]]> Fri, 30 Sep 2005 00:30:00 +0200 http://cws.huginonline.com/N/134323/PR/200509/1013736_5.html Novartis International AG <![CDATA[Novartis presents positive Phase III data on key compounds and highlights strong late-stage development pipeline]]> Tue, 20 Sep 2005 07:29:00 +0200 http://cws.huginonline.com/N/134323/PR/200509/1012406_5.html Novartis International AG <![CDATA[New data show that Novartis' indacaterol provides 24-hour efficacy with single dose in patients with asthma and COPD]]> Mon, 19 Sep 2005 07:30:00 +0200 http://cws.huginonline.com/N/134323/PR/200509/1012245_5.html Novartis International AG <![CDATA[Three-year study confirms long-term benefits of Xolair® for patients with severe allergic asthma]]> Mon, 19 Sep 2005 07:30:00 +0200 http://cws.huginonline.com/N/134323/PR/200509/1012241_5.html Novartis International AG <![CDATA[Sandoz Files Lawsuit Seeking FDA Ruling on Omnitrope]]> Tue, 13 Sep 2005 12:00:00 +0200 http://cws.huginonline.com/N/134323/PR/200509/1013636_5.html Novartis International AG <![CDATA[Novartis and Alnylam create major alliance to discover RNAi therapeutics]]> Wed, 7 Sep 2005 12:00:00 +0200 http://cws.huginonline.com/N/134323/PR/200509/1013638_5.html Novartis International AG <![CDATA[Novartis makes offer to independent directors to buy remaining stake in Chiron]]> Thu, 1 Sep 2005 07:20:00 +0200 http://cws.huginonline.com/N/134323/PR/200509/1009303_5.html Novartis International AG <![CDATA[Aclasta® superior to risedronate for Paget's disease of the bone in head-to-head study published by The New England Journal of Medicine]]> Wed, 31 Aug 2005 23:00:00 +0200 http://cws.huginonline.com/N/134323/PR/200508/1009286_5.html Novartis International AG <![CDATA[Novartis: Femara® granted FDA priority review for new indication as adjuvant treatment for postmenopausal women with early breast cancer]]> Mon, 29 Aug 2005 07:30:00 +0200 http://cws.huginonline.com/N/134323/PR/200508/1008779_5.html Novartis International AG <![CDATA[Novartis acquires rights to develop and commercialize new treatment for hyperphosphatemia in kidney dialysis patients]]> Thu, 18 Aug 2005 07:30:00 +0200 http://cws.huginonline.com/N/134323/PR/200508/1007014_5.html Novartis International AG <![CDATA[Novartis receives FDA approval for Diovan® (valsartan) to reduce cardiovascular death in heart attack survivors at high risk]]> Wed, 3 Aug 2005 08:00:00 +0200 http://cws.huginonline.com/N/134323/PR/200508/1009397_5.html Novartis International AG <![CDATA[Telbivudine achieves primary endpoint in Phase III GLOBE trial, largest ever registration trial in Hepatitis B]]> Thu, 28 Jul 2005 22:00:00 +0200 http://cws.huginonline.com/N/134323/PR/200507/1004045_5.html Novartis International AG <![CDATA[Novartis receives positive opinion recommending European approval of first-in-class asthma treatment Xolair® (omalizumab)]]> Thu, 28 Jul 2005 19:07:37 +0200 http://cws.huginonline.com/N/134323/PR/200507/1004258_5.html Novartis International AG <![CDATA[Novartis: Planned interim analysis of CONFIRM 2 trial of PTK/ZK indicates low probability of demonstrating overall survival benefit in second-line therapy for metastatic colorectal cancer]]> Thu, 28 Jul 2005 07:30:00 +0200 http://cws.huginonline.com/N/134323/PR/200507/1004091_5.html Novartis International AG <![CDATA[Novartis announces final results of Eon Labs tender offer]]> Wed, 27 Jul 2005 10:59:00 +0200 http://cws.huginonline.com/N/134323/PR/200507/1003942_5.html Novartis International AG <![CDATA[Novartis completes acquisition of 98% of Eon Labs, substantially strengthening the leading position of its Sandoz generics unit]]> Thu, 21 Jul 2005 14:00:00 +0200 http://cws.huginonline.com/N/134323/PR/200507/1003309_5.html Novartis International AG <![CDATA[Novartis completes tender offer for Eon Labs, Inc. and purchase of majority stake]]> Thu, 21 Jul 2005 10:52:01 +0200 http://cws.huginonline.com/N/134323/PR/200507/1003329_5.html Novartis International AG <![CDATA[Novartis receives US regulatory approval for completion of Eon Labs acquisition]]> Tue, 19 Jul 2005 17:30:00 +0200 http://cws.huginonline.com/N/134323/PR/200507/1003039_5.html Novartis International AG <![CDATA[New data from two leading clinical studies show Lucentis® is first therapy to improve vision in patients with wet age-related macular degeneration (AMD)]]> Mon, 18 Jul 2005 18:41:00 +0200 http://cws.huginonline.com/N/134323/PR/200507/1002762_5.html Novartis International AG <![CDATA[Novartis to acquire North American OTC brand portfolio from Bristol-Myers Squibb]]> Thu, 14 Jul 2005 22:00:00 +0200 http://cws.huginonline.com/N/134323/PR/200507/1002514_5.html Novartis International AG <![CDATA[Novartis reports strong results in the first six months of 2005]]> Thu, 14 Jul 2005 07:15:00 +0200 http://cws.huginonline.com/N/134323/PR/200507/1002329_5.html Novartis International AG <![CDATA[Novartis submits applications in US and Europe for Femara® as adjuvant treatment for postmenopausal women with early breast cancer]]> Mon, 11 Jul 2005 07:30:00 +0200 http://cws.huginonline.com/N/134323/PR/200507/1001822_5.html Novartis International AG <![CDATA[Novartis reaches agreement to settle US lawsuit related to Eon Labs acquisition]]> Fri, 8 Jul 2005 20:37:14 +0200 http://cws.huginonline.com/N/134323/PR/200507/1001858_5.html Novartis International AG <![CDATA[Novartis and Procter & Gamble enter into commercialization agreement for Enablex®]]> Wed, 6 Jul 2005 17:30:00 +0200 http://cws.huginonline.com/N/134323/PR/200507/1001607_5.html Novartis International AG <![CDATA[Novartis extends tender offer for Eon Labs, Inc. through July 13, 2005]]> Tue, 5 Jul 2005 13:00:00 +0200 http://cws.huginonline.com/N/134323/PR/200507/1001372_5.html Novartis International AG <![CDATA[Xolair® (omalizumab) add-on therapy significantly reduces attacks in patients with severe allergic asthma]]> Fri, 1 Jul 2005 07:30:00 +0200 http://cws.huginonline.com/N/134323/PR/200507/1001039_5.html Novartis International AG <![CDATA[Novartis licenses rights to develop and commercialize new respiratory syncytial virus (RSV) treatment]]> Thu, 30 Jun 2005 07:30:00 +0200 http://cws.huginonline.com/N/134323/PR/200506/1000677_5.html Novartis International AG <![CDATA[FDA grants priority review for Exjade® for the treatment of chronic iron overload due to blood transfusions]]> Wed, 22 Jun 2005 07:29:00 +0200 http://cws.huginonline.com/N/134323/PR/200506/999551_5.html Novartis International AG <![CDATA[FTY720, a novel once-daily oral medication, shows promising results in treatment of multiple sclerosis]]> Tue, 21 Jun 2005 16:44:00 +0200 http://cws.huginonline.com/N/134323/PR/200506/999521_5.html Novartis International AG <![CDATA[Novartis extends tender offer for Eon Labs, Inc. through July 1, 2005]]> Tue, 21 Jun 2005 13:00:00 +0200 http://cws.huginonline.com/N/134323/PR/200506/999409_5.html Novartis International AG <![CDATA[New data reinforce powerful blood pressure-lowering efficacy with Diovan®/Co-Diovan® based regimens]]> Mon, 20 Jun 2005 07:30:00 +0200 http://cws.huginonline.com/N/134323/PR/200506/999118_5.html Novartis International AG <![CDATA[Novartis receives EU marketing authorization for Diovan© to treat people with heart failure]]> Mon, 13 Jun 2005 07:30:00 +0200 http://cws.huginonline.com/N/134323/PR/200506/998132_5.html Novartis International AG <![CDATA[Cornerstone laid for new Pharmaceutical Development sterile pilot plant at Novartis site in Stein]]> Wed, 8 Jun 2005 08:00:00 +0200 http://cws.huginonline.com/N/134323/PR/200506/1009391_5.html Novartis International AG <![CDATA[Novartis announces completion of Hexal AG acquisition, integrates company with Sandoz]]> Tue, 7 Jun 2005 07:30:00 +0200 http://cws.huginonline.com/N/134323/PR/200506/997404_5.html Novartis International AG <![CDATA[Novartis partners with East African Botanicals to expand cultivation and extraction of natural ingredient used in anti-malarial Coartem®]]> Mon, 6 Jun 2005 11:30:35 +0200 http://cws.huginonline.com/N/134323/PR/200506/997306_5.html Novartis International AG <![CDATA[Novartis licenses rights to develop and commercialize new hepatitis treatment]]> Thu, 2 Jun 2005 07:30:00 +0200 http://cws.huginonline.com/N/134323/PR/200506/996839_5.html Novartis International AG <![CDATA[Novartis receives European Commission approval to acquire Hexal AG,]]> Fri, 27 May 2005 13:19:01 +0200 http://cws.huginonline.com/N/134323/PR/200505/996147_5.html Novartis International AG <![CDATA[Xolair® halves rate of severe exacerbations and significantly improves quality of life in patients at risk of life-threatening asthma attacks]]> Thu, 26 May 2005 17:30:00 +0200 http://cws.huginonline.com/N/134323/PR/200505/996037_5.html Novartis International AG <![CDATA[Public access to the Rhine bank between the "Dreirosenbrücke" bridge and the border with France - joint action to be taken by the cantonal authorities and Novartis]]> Thu, 26 May 2005 08:00:00 +0200 http://cws.huginonline.com/N/134323/PR/200505/1009385_5.html Novartis International AG <![CDATA[Preliminary phase III data show Lucentis(TM) maintained or improved vision in nearly 95% of patients with wet age-related macular degeneration]]> Mon, 23 May 2005 22:08:47 +0200 http://cws.huginonline.com/N/134323/PR/200505/995507_5.html Novartis International AG <![CDATA[Novartis unveils promising Phase II data for bronchodilator QAB149]]> Mon, 23 May 2005 17:30:00 +0200 http://cws.huginonline.com/N/134323/PR/200505/995472_5.html Novartis International AG <![CDATA[Novartis hosts first Career Guidance Conference in Life Sciences]]> Thu, 19 May 2005 11:00:00 +0200 http://cws.huginonline.com/N/134323/PR/200505/994911_5.html Novartis International AG <![CDATA[Certican© approved by Swissmedic to reduce risk of organ rejection in heart and kidney transplant patients]]> Wed, 18 May 2005 07:30:00 +0200 http://cws.huginonline.com/N/134323/PR/200505/994719_5.html Novartis International AG <![CDATA[New data show Zometa® significantly improved bone mineral density in breast cancer patients receiving adjuvant therapy]]> Sun, 15 May 2005 19:00:00 +0200 http://cws.huginonline.com/N/134323/PR/200505/994461_5.html Novartis International AG <![CDATA[First results from PTK/ZK CONFIRM 1 trial presented at American Society of Clinical Oncology show positive drug effects in advanced colorectal cancer]]> Fri, 13 May 2005 22:00:00 +0200 http://cws.huginonline.com/N/134323/PR/200505/994428_5.html Novartis International AG <![CDATA[Femara helped significantly more women with early breast cancer live free of cancer compared with tamoxifen, study presented today shows]]> Fri, 13 May 2005 22:00:00 +0200 http://cws.huginonline.com/N/134323/PR/200505/994424_5.html Novartis International AG <![CDATA[Diovan® receives EU approval for the treatment of heart attack survivors]]> Mon, 9 May 2005 07:30:00 +0200 http://cws.huginonline.com/N/134323/PR/200505/993017_5.html Novartis International AG <![CDATA[Novartis files Exjade® new drug applications for treatment of chronic iron overload due to blood transfusions]]> Tue, 3 May 2005 07:30:00 +0200 http://cws.huginonline.com/N/134323/PR/200505/992462_5.html Novartis International AG <![CDATA[Novartis highlights pharmaceutical research strategy, intensifying focus on molecular pathways shared by various diseases]]> Tue, 3 May 2005 07:30:00 +0200 http://cws.huginonline.com/N/134323/PR/200505/992453_5.html Novartis International AG <![CDATA[New study finds Coartem® (artemether-lumefantrine) is the most effective malaria treatment in areas of high resistance to conventional anti-malarials]]> Tue, 26 Apr 2005 18:08:29 +0200 http://cws.huginonline.com/N/134323/PR/200504/991237_5.html Novartis International AG <![CDATA[Novartis provides progress update on plans to integrate Hexal and Eon Labs with Sandoz]]> Tue, 26 Apr 2005 09:35:00 +0200 http://cws.huginonline.com/N/134323/PR/200504/991038_5.html Novartis International AG <![CDATA[Novartis receives European marketing authorization for Aclasta®]]> Thu, 21 Apr 2005 07:45:00 +0200 http://cws.huginonline.com/N/134323/PR/200504/990207_5.html Novartis International AG <![CDATA[Novartis continues to outpace the market, delivering strong first quarter 2005 sales and earnings growth]]> Thu, 21 Apr 2005 07:14:00 +0200 http://cws.huginonline.com/N/134323/PR/200504/990225_5.html Novartis International AG <![CDATA[Novartis announces agreement to develop and commercialize new treatment for chronic obstructive pulmonary disease]]> Wed, 13 Apr 2005 08:00:00 +0200 http://cws.huginonline.com/N/134323/PR/200504/988894_5.html Novartis International AG <![CDATA[Novartis provides update on regulatory developments regarding its pending acquisitions of Hexal AG and Eon Labs]]> Fri, 8 Apr 2005 09:32:51 +0200 http://cws.huginonline.com/N/134323/PR/200504/988318_5.html Novartis International AG <![CDATA[PTK/ZK CONFIRM 1 Study Shows Positive Drug Effects in Phase III Study in Metastatic Colorectal Cancer, Filing Now Anticipated for Early 2007]]> Mon, 21 Mar 2005 06:00:00 +0100 http://cws.huginonline.com/N/134323/PR/200503/985846_5.html Novartis International AG <![CDATA[Novartis investigational renin inhibitor Aliskiren offers once-daily, dose-dependent blood pressure reductions]]> Thu, 10 Mar 2005 07:30:00 +0100 http://cws.huginonline.com/N/134323/PR/200503/984110_5.html Novartis International AG <![CDATA[Femara® approved in Germany as the only hormonal therapy given after standard tamoxifen for post-menopausal woman with early breast cancer]]> Fri, 4 Mar 2005 07:45:00 +0100 http://cws.huginonline.com/N/134323/PR/200503/983394_5.html Novartis International AG <![CDATA[Novartis shareholders approve eighth consecutive dividend increase and fifth share buyback program]]> Tue, 1 Mar 2005 14:13:50 +0100 http://cws.huginonline.com/N/134323/PR/200503/982764_5.html Novartis International AG <![CDATA[Novartis receives 2005 Excellence in Corporate Philanthropy Award]]> Mon, 28 Feb 2005 17:30:00 +0100 http://cws.huginonline.com/N/134323/PR/200502/982550_5.html Novartis International AG <![CDATA[New study shows Elidel® provides sustained control of eczema and improves patients' quality of life]]> Mon, 21 Feb 2005 17:30:00 +0100 http://cws.huginonline.com/N/134323/PR/200502/981623_5.html Novartis International AG <![CDATA[Novartis to acquire Hexal AG and Eon Labs, creating the world leader]]> Mon, 21 Feb 2005 07:30:00 +0100 http://cws.huginonline.com/N/134323/PR/200502/981486_5.html Novartis International AG <![CDATA[Xolair® significantly reduces asthma attacks and emergency treatment in patients most at risk of asthma-related death]]> Tue, 15 Feb 2005 08:00:00 +0100 http://cws.huginonline.com/N/134323/PR/200502/980489_5.html Novartis International AG <![CDATA[Novartis obtains rights from Otsuka to develop new treatment for dry eye]]> Mon, 7 Feb 2005 07:30:00 +0100 http://cws.huginonline.com/N/134323/PR/200502/979042_5.html Novartis International AG <![CDATA[Novartis seeks shareholder approval for new share repurchase program]]> Fri, 4 Feb 2005 07:30:00 +0100 http://cws.huginonline.com/N/134323/PR/200502/978908_5.html Novartis International AG <![CDATA[Novartis Venture Fund invests USD 28 million in new capital in 2004]]> Fri, 28 Jan 2005 11:03:50 +0100 http://cws.huginonline.com/N/134323/PR/200501/977901_5.html Novartis International AG <![CDATA[First results of major study show that Femara® provides a disease free survival advantage vs. tamoxifen in adjuvant treatment of early breast cancer]]> Wed, 26 Jan 2005 19:15:22 +0100 http://cws.huginonline.com/N/134323/PR/200501/977618_5.html Novartis International AG <![CDATA[Ad hoc: Novartis and Schering AG finalize commercialization agreement]]> Tue, 25 Jan 2005 07:30:32 +0100 http://cws.huginonline.com/N/134323/PR/200501/977209_5.html Novartis International AG <![CDATA[Novartis receives positive CHMP opinion recommending EU approval for Aclasta® to treat Paget's disease of the bone]]> Thu, 20 Jan 2005 17:00:00 +0100 http://cws.huginonline.com/N/134323/PR/200501/976799_5.html Novartis International AG <![CDATA[Novartis grants marketing rights for antihypertension medicines Cibacen and Cibadrex in most EU markets]]> Thu, 20 Jan 2005 07:00:00 +0100 http://cws.huginonline.com/N/134323/PR/200501/976579_5.html Novartis International AG <![CDATA[Novartis shows dynamic momentum in industry-leading pipeline]]> Thu, 20 Jan 2005 06:55:00 +0100 http://cws.huginonline.com/N/134323/PR/200501/976581_5.html Novartis International AG <![CDATA[Novartis delivers record results with strong double-digit net sales and earnings growth in 2004]]> Thu, 20 Jan 2005 06:55:00 +0100 http://cws.huginonline.com/N/134323/PR/200501/976580_5.html Novartis International AG <![CDATA[Novartis shows dynamic momentum in industry-leading pipeline]]> Thu, 20 Jan 2005 00:36:40 +0100 http://cws.huginonline.com/N/134323/PR/200501/976583_5.html Novartis International AG <![CDATA[Novartis providing over USD 2 million in immediate emergency aid for victims of Southeast Asian disaster]]> Thu, 6 Jan 2005 14:00:00 +0100 http://cws.huginonline.com/N/134323/PR/200501/975155_5.html Novartis International AG <![CDATA[FDA approves Enablex for treatment of overactive bladder]]> Thu, 23 Dec 2004 08:00:00 +0100 http://cws.huginonline.com/N/134323/PR/200412/973471_5.html Novartis International AG <![CDATA[Novartis ramps up Coartem® production to provide potentially life- saving medicine to more patients]]> Wed, 22 Dec 2004 14:00:00 +0100 http://cws.huginonline.com/N/134323/PR/200412/973414_5.html Novartis International AG <![CDATA[Novartis announces commercialization collaboration in Germany for Emselex® for the treatment of overactive bladder]]> Fri, 17 Dec 2004 07:30:00 +0100 http://cws.huginonline.com/N/134323/PR/200412/972662_5.html Novartis International AG <![CDATA[Landmark study in New England Journal of Medicine shows Exelon® may help people suffering from dementia associated with Parkinson's disease]]> Thu, 9 Dec 2004 07:30:00 +0100 http://cws.huginonline.com/N/134323/PR/200412/971636_5.html Novartis International AG <![CDATA[Novartis investigational drug ICL670 demonstrates positive results in treating chronic iron overload, a potentially life-threatening condition]]> Tue, 7 Dec 2004 07:30:00 +0100 http://cws.huginonline.com/N/134323/PR/200412/971414_5.html Novartis International AG <![CDATA[New Glivec data: Prolonged efficacy with approved 400 mg daily dose and potential for improved response at higher dose]]> Mon, 6 Dec 2004 07:30:00 +0100 http://cws.huginonline.com/N/134323/PR/200412/971324_5.html Novartis International AG <![CDATA[Results from two new multi-center trials confirm efficacy and tolerability of Prexige® 100 mg once daily in treatment of osteoarthritis]]> Mon, 6 Dec 2004 07:30:00 +0100 http://cws.huginonline.com/N/134323/PR/200412/971321_5.html Novartis International AG <![CDATA[Novartis Foundation for Sustainable Development celebrates 25th anniversary with symposium on the "Right to Health: A Duty for Whom?"]]> Thu, 2 Dec 2004 15:00:00 +0100 http://cws.huginonline.com/N/134323/PR/200412/971110_5.html Novartis International AG <![CDATA[Certican® European Union Mutual Recognition Procedure expanded to include 10 new EU Member States]]> Wed, 1 Dec 2004 17:00:00 +0100 http://cws.huginonline.com/N/134323/PR/200412/971008_5.html Novartis International AG <![CDATA[Diovan® receives approval in Sweden to treat high-risk heart attack patients]]> Wed, 1 Dec 2004 07:30:00 +0100 http://cws.huginonline.com/N/134323/PR/200412/970821_5.html Novartis International AG <![CDATA[Following EMEA decision to review safety of COX-2 class, Novartis temporarily withdraws EU Mutual Recognition Procedure application for Prexige®]]> Tue, 30 Nov 2004 07:30:00 +0100 http://cws.huginonline.com/N/134323/PR/200411/970628_5.html Novartis International AG <![CDATA[Eczema patients face a lifetime of isolation, bullying, discrimination and under-performance at school and work]]> Thu, 18 Nov 2004 10:24:05 +0100 http://cws.huginonline.com/N/134323/PR/200411/969585_5.html Novartis International AG <![CDATA[Study explores whether long-term treatment of eczema with Elidel® could reduce risk of asthma by halting "atopic march"]]> Thu, 18 Nov 2004 08:00:00 +0100 http://cws.huginonline.com/N/134323/PR/200411/1011592_5.html Novartis International AG <![CDATA[Novartis honors scientists for outstanding contributions to research and development]]> Mon, 15 Nov 2004 11:47:28 +0100 http://cws.huginonline.com/N/134323/PR/200411/969086_5.html Novartis International AG <![CDATA[Femara gains U.S. FDA approval as only post-tamoxifen treatment for early breast cancer]]> Mon, 1 Nov 2004 08:00:00 +0100 http://cws.huginonline.com/N/134323/PR/200411/1011598_5.html Novartis International AG <![CDATA[Novartis receives European marketing authorization for Emselex®]]> Wed, 27 Oct 2004 08:00:00 +0200 http://cws.huginonline.com/N/134323/PR/200410/1011607_5.html Novartis International AG <![CDATA[Novartis Institute for Tropical Diseases and TB Alliance announce partnership to develop novel tuberculosis drugs]]> Wed, 27 Oct 2004 08:00:00 +0200 http://cws.huginonline.com/N/134323/PR/200410/1011602_5.html Novartis International AG <![CDATA[Novartis and Orion Pharma launch first Parkinson's disease study to explore potential of delaying motor complications with Stalevo®]]> Tue, 26 Oct 2004 00:00:00 +0200 http://cws.huginonline.com/N/134323/PR/200410/1011608_5.html Novartis International AG <![CDATA[Novartis delivers strong double-digit growth and margin expansion in first nine months and third quarter of 2004]]> Thu, 21 Oct 2004 08:00:00 +0200 http://cws.huginonline.com/N/134323/PR/200410/1011830_5.html Novartis International AG <![CDATA[Australian agency approves Omnitrope]]> Mon, 4 Oct 2004 09:00:00 +0200 http://cws.huginonline.com/N/134323/PR/200410/1011827_5.html Novartis International AG <![CDATA[Bernard Fraisse Group to acquire Novartis production site in Hettlingen (CH)]]> Thu, 30 Sep 2004 08:00:00 +0200 http://cws.huginonline.com/N/134323/PR/200409/1011622_5.html Novartis International AG <![CDATA[Landmark ZENSAA trial shows Zelnorm® is effective in repeated treatment of Irritable Bowel Syndrome with Constipation]]> Mon, 27 Sep 2004 08:00:00 +0200 http://cws.huginonline.com/N/134323/PR/200409/1011623_5.html Novartis International AG <![CDATA[Largest study in gastrointestinal stromal tumor patients shows higher dose of Glivec® significantly improves progression-free survival]]> Fri, 24 Sep 2004 07:00:00 +0200 http://cws.huginonline.com/N/134323/PR/200409/1011625_5.html Novartis International AG <![CDATA[Novartis expands Diovan® production at Swiss manufacturing site]]> Wed, 22 Sep 2004 08:00:00 +0200 http://cws.huginonline.com/N/134323/PR/200409/1011626_5.html Novartis International AG <![CDATA[LAF237, first in a new class of oral antidiabetic agents, shown in phase II to provide clinically significant improvement in glycemic control]]> Tue, 7 Sep 2004 08:00:00 +0200 http://cws.huginonline.com/N/134323/PR/200409/1011628_5.html Novartis International AG <![CDATA[Novartis wins Lamisil Tablets® patent infringement lawsuit against Dr. Reddy's Laboratories]]> Fri, 3 Sep 2004 08:00:00 +0200 http://cws.huginonline.com/N/134323/PR/200409/1011629_5.html Novartis International AG <![CDATA[FDA defers decision on Omnitrope application]]> Thu, 2 Sep 2004 08:00:00 +0200 http://cws.huginonline.com/N/134323/PR/200409/1011821_5.html Novartis International AG <![CDATA[Novartis honors researchers committed to advancing the understanding and treatment of diabetes]]> Wed, 1 Sep 2004 09:00:00 +0200 http://cws.huginonline.com/N/134323/PR/200409/1011631_5.html Novartis International AG <![CDATA[NAVIGATOR trial investigators call for closer attention to glucose levels]]> Tue, 31 Aug 2004 09:00:00 +0200 http://cws.huginonline.com/N/134323/PR/200408/1011633_5.html Novartis International AG <![CDATA[FDA issues "approvable letter" for Certican®]]> Mon, 30 Aug 2004 12:00:00 +0200 http://cws.huginonline.com/N/134323/PR/200408/1011634_5.html Novartis International AG <![CDATA[FDA Approves Zelnorm as the First Rx Therapy For Chronic Constipation]]> Mon, 23 Aug 2004 12:00:00 +0200 http://cws.huginonline.com/N/134323/PR/200408/1011635_5.html Novartis International AG <![CDATA[Prexige® is first COX-2 selective inhibitor to significantly reduce gastrointestinal events without compromising cardiovascular safety compared to NSAIDs1,2]]> Fri, 20 Aug 2004 12:00:00 +0200 http://cws.huginonline.com/N/134323/PR/200408/1011637_5.html Novartis International AG <![CDATA[Novartis completes Sabex acquisition]]> Mon, 16 Aug 2004 08:00:00 +0200 http://cws.huginonline.com/N/134323/PR/200408/1011817_5.html Novartis International AG <![CDATA[Femara gains approval in Switzerland as only post-tamoxifen treatment for early breast cancer]]> Thu, 12 Aug 2004 12:00:00 +0200 http://cws.huginonline.com/N/134323/PR/200408/1011638_5.html Novartis International AG <![CDATA[Novartis to launch new CHF 3 billion share buy-back program]]> Mon, 9 Aug 2004 09:00:00 +0200 http://cws.huginonline.com/N/134323/PR/200408/1011788_5.html Novartis International AG <![CDATA[Emselex® Receives Positive CHMP Opinion for the Treatment Of Overactive Bladder]]> Fri, 30 Jul 2004 08:00:00 +0200 http://cws.huginonline.com/N/134323/PR/200407/1011786_5.html Novartis International AG <![CDATA[Novartis reports strong double-digit growth in sales and income]]> Tue, 20 Jul 2004 09:00:00 +0200 http://cws.huginonline.com/N/134323/PR/200407/1011784_5.html Novartis International AG <![CDATA[Approval recommended for use of Zelnorm® in chronic constipation by FDA Advisory Committee]]> Wed, 14 Jul 2004 09:00:00 +0200 http://cws.huginonline.com/N/134323/PR/200407/1011783_5.html Novartis International AG <![CDATA[Novartis Institute for Tropical Diseases opens in Singapore's state-of-the-art Biopolis research facility]]> Mon, 5 Jul 2004 08:00:00 +0200 http://cws.huginonline.com/N/134323/PR/200407/1011781_5.html Novartis International AG <![CDATA[Novartis seeks European approval for Xolair®]]> Fri, 2 Jul 2004 12:00:00 +0200 http://cws.huginonline.com/N/134323/PR/200407/1011779_5.html Novartis International AG <![CDATA[Sandoz acquires Durascan]]> Wed, 30 Jun 2004 08:00:00 +0200 http://cws.huginonline.com/N/134323/PR/200406/1011812_5.html Novartis International AG <![CDATA[U.S. FDA grants priority review for Femara for new indication as first ever post-tamoxifen treatment for early breast cancer in postmenopausal women]]> Tue, 29 Jun 2004 09:00:00 +0200 http://cws.huginonline.com/N/134323/PR/200406/1011778_5.html Novartis International AG <![CDATA[Leading European agency recognises clinical and cost-effectiveness of steroid-free Elidel cream for treating eczema]]> Mon, 28 Jun 2004 09:00:00 +0200 http://cws.huginonline.com/N/134323/PR/200406/1011776_5.html Novartis International AG <![CDATA[SANDOZ INC. LAUNCHES AB-RATED LEVOTHYROXINE]]> Thu, 24 Jun 2004 09:00:00 +0200 http://cws.huginonline.com/N/134323/PR/200406/1011774_5.html Novartis International AG <![CDATA[The VALUE trial complements the long-term cardioprotective profile of Diovan]]> Mon, 14 Jun 2004 09:00:00 +0200 http://cws.huginonline.com/N/134323/PR/200406/1011765_5.html Novartis International AG <![CDATA[Novartis unveils promising new clinical data of key pipeline projects at the Goldman Sachs Healthcare Conference in Laguna Niguel]]> Wed, 9 Jun 2004 12:00:00 +0200 http://cws.huginonline.com/N/134323/PR/200406/1011963_5.html Novartis International AG <![CDATA[Femara® Is First Hormonal Therapy To Significantly Reduce Spread Of Early Breast Cancer To Other Parts Of The Body After Standard Tamoxifen Treatment In Postmenopausal Women]]> Tue, 8 Jun 2004 12:00:00 +0200 http://cws.huginonline.com/N/134323/PR/200406/1011762_5.html Novartis International AG <![CDATA[Positive results of first phase II study in new class of oral diabetes drugs]]> Mon, 7 Jun 2004 09:00:00 +0200 http://cws.huginonline.com/N/134323/PR/200406/1011761_5.html Novartis International AG <![CDATA[New clinically important BP efficacy data with Novartis' antihypertensives Diovan® and Co-Diovan® presented at leading hypertension meeting]]> Fri, 21 May 2004 12:00:00 +0200 http://cws.huginonline.com/N/134323/PR/200405/947641_5.html Novartis International AG <![CDATA[Single dose of Zoledronic acid yields significantly higher, faster response rates than standard Paget's disease therapy, new study shows]]> Tue, 18 May 2004 12:00:00 +0200 http://cws.huginonline.com/N/134323/PR/200405/947643_5.html Novartis International AG <![CDATA[Sandoz strengthens global production network with three new facilities]]> Tue, 18 May 2004 09:00:00 +0200 http://cws.huginonline.com/N/134323/PR/200405/1011758_5.html Novartis International AG <![CDATA[Novartis marks 20 years of improving patients' lives with innovative treatments for transplantation]]> Fri, 14 May 2004 09:00:00 +0200 http://cws.huginonline.com/N/134323/PR/200405/1011754_5.html Novartis International AG <![CDATA[Novartis major investment in Poland]]> Wed, 12 May 2004 09:00:00 +0200 http://cws.huginonline.com/N/134323/PR/200405/1011750_5.html Novartis International AG <![CDATA[Visudyne® launched in Japan]]> Mon, 10 May 2004 09:00:00 +0200 http://cws.huginonline.com/N/134323/PR/200405/1011748_5.html Novartis International AG <![CDATA[Novartis Files Femara Applications]]> Mon, 10 May 2004 09:00:00 +0200 http://cws.huginonline.com/N/134323/PR/200405/1011746_5.html Novartis International AG <![CDATA[Novartis Announced Today It Did Not Submit a Bid for a Potential Combination of Aventis and Novartis]]> Sun, 25 Apr 2004 09:00:00 +0200 http://cws.huginonline.com/N/134323/PR/200404/1011745_5.html Novartis International AG <![CDATA[Novartis drug Sandostatin® LAR® approved in Japan for acromegaly and symptoms of gastrointestinal hormone secreting tumors]]> Fri, 23 Apr 2004 09:00:00 +0200 http://cws.huginonline.com/N/134323/PR/200404/1011743_5.html Novartis International AG <![CDATA[Novartis Q1 results 2004]]> Thu, 22 Apr 2004 09:00:00 +0200 http://cws.huginonline.com/N/134323/PR/200404/1011742_5.html Novartis International AG <![CDATA[SANDOZ INC. LAUNCHES GENERIC REBETOL®]]> Wed, 7 Apr 2004 12:00:00 +0200 http://cws.huginonline.com/N/134323/PR/200404/1011962_5.html Novartis International AG <![CDATA[Novartis acknowledges Aventis invitation]]> Fri, 2 Apr 2004 09:00:00 +0200 http://cws.huginonline.com/N/134323/PR/200404/1011738_5.html Novartis International AG <![CDATA[Novartis clarifies position regarding Aventis]]> Tue, 23 Mar 2004 09:00:00 +0100 http://cws.huginonline.com/N/134323/PR/200403/1011733_5.html Novartis International AG <![CDATA[Novartis responds to request by French market authority]]> Fri, 12 Mar 2004 07:55:00 +0100 http://cws.huginonline.com/N/134323/PR/200403/937772_5.html Novartis International AG <![CDATA[Dr. Vasella Highlights Important Role of Lek in Global Development Network of Sandoz]]> Fri, 5 Mar 2004 08:00:00 +0100 http://cws.huginonline.com/N/134323/PR/200403/1011731_5.html Novartis International AG <![CDATA[FDA approves Myfortic® to prevent organ rejection after kidney transplantation]]> Mon, 1 Mar 2004 07:30:00 +0100 http://cws.huginonline.com/N/134323/PR/200403/936239_5.html Novartis International AG <![CDATA[Novartis, Genentech and Tanox settle disputes surrounding Xolair and TNX-901]]> Thu, 26 Feb 2004 09:00:00 +0100 http://cws.huginonline.com/N/134323/PR/200402/1011728_5.html Novartis International AG <![CDATA[Novartis General Assembly]]> Tue, 24 Feb 2004 09:00:00 +0100 http://cws.huginonline.com/N/134323/PR/200402/1011727_5.html Novartis International AG <![CDATA[Novartis completes strategic acquisition in global medical nutrition business]]> Tue, 17 Feb 2004 08:00:00 +0100 http://cws.huginonline.com/N/134323/PR/200402/1011726_5.html Novartis International AG <![CDATA[New European study: Zelmac significantly improves IBS symptoms]]> Fri, 13 Feb 2004 07:30:00 +0100 http://cws.huginonline.com/N/134323/PR/200402/934203_5.html Novartis International AG <![CDATA[Novartis launches Spanish version of its global website]]> Wed, 11 Feb 2004 09:00:00 +0100 http://cws.huginonline.com/N/134323/PR/200402/1011725_5.html Novartis International AG <![CDATA[Novartis successfully completes European Mutual Recognition Procedure for Myfortic® - its new immunosuppressant]]> Tue, 10 Feb 2004 07:30:00 +0100 http://cws.huginonline.com/N/134323/PR/200402/933583_5.html Novartis International AG <![CDATA[Susan Gasser to head Friedrich Miescher Institute]]> Thu, 5 Feb 2004 08:30:00 +0100 http://cws.huginonline.com/N/134323/PR/200402/932973_5.html Novartis International AG <![CDATA[Sandoz powers up cell-culture production]]> Wed, 4 Feb 2004 07:00:00 +0100 http://cws.huginonline.com/N/134323/PR/200402/932778_5.html Novartis International AG <![CDATA[Jim Barrington appointed Chief Information Officer at Novartis]]> Fri, 30 Jan 2004 08:00:00 +0100 http://cws.huginonline.com/N/134323/PR/200401/1011722_5.html Novartis International AG <![CDATA[Novartis files application for new indication for Diovan®]]> Fri, 30 Jan 2004 07:30:00 +0100 http://cws.huginonline.com/N/134323/PR/200401/932350_5.html Novartis International AG <![CDATA[Biotech Center Huningue - VIRTUAL PRESS KIT]]> Fri, 23 Jan 2004 12:00:00 +0100 http://cws.huginonline.com/N/134323/PR/200401/1011961_5.html Novartis International AG <![CDATA[Novartis Financial Results 2003 - ENGLISH VIRTUAL PRESS KIT]]> Thu, 22 Jan 2004 12:00:00 +0100 http://cws.huginonline.com/N/134323/PR/200401/1012053_5.html Novartis International AG <![CDATA[New share repurchase program at Novartis]]> Thu, 22 Jan 2004 08:00:00 +0100 http://cws.huginonline.com/N/134323/PR/200401/1011720_5.html Novartis International AG <![CDATA[Novartis posts leading growth among top-ten pharmaceutical companies, sustaining double-digit increase in sales and operating income in 2003]]> Thu, 22 Jan 2004 08:00:00 +0100 http://cws.huginonline.com/N/134323/PR/200401/1011711_5.html Novartis International AG <![CDATA[Novartis 2003 Financial Results]]> Thu, 22 Jan 2004 07:15:00 +0100 http://cws.huginonline.com/N/134323/PR/200401/931477_5.html Novartis International AG <![CDATA[Media Alert: Novartis 2003 Financial Results]]> Tue, 20 Jan 2004 16:15:00 +0100 http://cws.huginonline.com/N/134323/PR/200401/931297_5.html Novartis International AG <![CDATA[Novartis Venture Fund supports innovative start-ups]]> Fri, 16 Jan 2004 10:00:00 +0100 http://cws.huginonline.com/N/134323/PR/200401/930917_5.html Novartis International AG <![CDATA[Novartis to acquire worldwide adult medical nutrition business of]]> Tue, 16 Dec 2003 07:28:00 +0100 http://cws.huginonline.com/N/134323/PR/200312/928373_5.html Novartis International AG <![CDATA[Sandoz acquires antibiotics production facility]]> Thu, 11 Dec 2003 07:30:00 +0100 http://cws.huginonline.com/N/134323/PR/200312/927878_5.html Novartis International AG <![CDATA[Novartis honors scientists]]> Tue, 9 Dec 2003 09:40:00 +0100 http://cws.huginonline.com/N/134323/PR/200312/927630_5.html Novartis International AG <![CDATA[New Data Show Higher Dosing of Gleevec Achieved Higher Response Rates in Patients with Newly Diagnosed Chronic Myeloid Leukemia (CML)]]> Mon, 8 Dec 2003 09:00:00 +0100 http://cws.huginonline.com/N/134323/PR/200312/1011694_5.html Novartis International AG <![CDATA[Post-tamoxifen Use Of Femara In Postmenopausal Women With Early Breast Cancer Reduced Risk Of Recurrence By Nearly Half (43%) and Significantly Improved Disease-Free Survival, According to Data Presented at Major Medical Meeting]]> Mon, 8 Dec 2003 09:00:00 +0100 http://cws.huginonline.com/N/134323/PR/200312/1011693_5.html Novartis International AG <![CDATA[Certican® successfully completes European Mutual Recognition Procedure]]> Wed, 3 Dec 2003 17:30:00 +0100 http://cws.huginonline.com/N/134323/PR/200312/927170_5.html Novartis International AG <![CDATA[Geneva Pharmaceuticals, Inc., renamed Sandoz, Inc. - New Name Symbolizes Global Strength -]]> Mon, 1 Dec 2003 12:00:00 +0100 http://cws.huginonline.com/N/134323/PR/200312/1011647_5.html Novartis International AG <![CDATA[Novartis presents new corporate guidelines on human rights]]> Thu, 27 Nov 2003 08:15:00 +0100 http://cws.huginonline.com/N/134323/PR/200311/926428_5.html Novartis International AG <![CDATA[Geneva prevails as U.S. district court upholds Augmentin® patents' invalidation]]> Fri, 21 Nov 2003 08:00:00 +0100 http://cws.huginonline.com/N/134323/PR/200311/1011804_5.html Novartis International AG <![CDATA[R&D Day Virtual Media Conference - ENGLISH VIRTUAL PRESS KIT]]> Wed, 19 Nov 2003 08:00:00 +0100 http://cws.huginonline.com/N/134323/PR/200311/1011802_5.html Novartis International AG <![CDATA[Industry leading pipeline to bring novel treatments to patients and sustain above-market growth at Novartis]]> Wed, 19 Nov 2003 05:30:00 +0100 http://cws.huginonline.com/N/134323/PR/200311/925519_5.html Novartis International AG <![CDATA[Pre-Announcement Novartis' 2003 "R&D day"]]> Mon, 17 Nov 2003 12:00:00 +0100 http://cws.huginonline.com/N/134323/PR/200311/1011646_5.html Novartis International AG <![CDATA[Landmark Diovan® (valsartan) mega-trial proves life-saving benefits for heart attack sufferers]]> Mon, 10 Nov 2003 12:00:00 +0100 http://cws.huginonline.com/N/134323/PR/200311/1011644_5.html Novartis International AG <![CDATA[Medicines for Malaria Venture and Novartis agree to develop a pediatric formulation of Coartem®]]> Mon, 10 Nov 2003 08:00:00 +0100 http://cws.huginonline.com/N/134323/PR/200311/1011799_5.html Novartis International AG <![CDATA[Novartis signs license agreement to develop and globally commercialize cancer-compound Gimatecan from Sigma-Tau]]> Thu, 6 Nov 2003 12:00:00 +0100 http://cws.huginonline.com/N/134323/PR/200311/1011643_5.html Novartis International AG <![CDATA[UK and Australian health authorities endorse use of Glivec® for first-line treatment of chronic myeloid leukemia patients]]> Thu, 30 Oct 2003 07:30:00 +0100 http://cws.huginonline.com/N/134323/PR/200310/922709_5.html Novartis International AG <![CDATA[EMEA approves StalevoTM]]> Thu, 23 Oct 2003 17:31:00 +0200 http://cws.huginonline.com/N/134323/PR/200310/921897_5.html Novartis International AG <![CDATA[FDA issues "approvable" letter for Certican®]]> Tue, 21 Oct 2003 09:18:44 +0200 http://cws.huginonline.com/N/134323/PR/200310/921303_5.html Novartis International AG <![CDATA[Novartis outpaces the market with double-digit sales growth and further market share gains in the first nine months of 2003]]> Mon, 20 Oct 2003 07:15:00 +0200 http://cws.huginonline.com/N/134323/PR/200310/921061_5.html Novartis International AG <![CDATA[Visudyne® approved in Japan]]> Thu, 16 Oct 2003 07:30:00 +0200 http://cws.huginonline.com/N/134323/PR/200310/920738_5.html Novartis International AG <![CDATA[Darifenacin increases "warning time" for OAB sufferers]]> Fri, 10 Oct 2003 07:30:00 +0200 http://cws.huginonline.com/N/134323/PR/200310/920068_5.html Novartis International AG <![CDATA[Compelling disease-free survival results in breast cancer trial prompt independent researchers to offer patients the opportunity to switch to Femara, as reported in New England Journal of Medicine]]> Thu, 9 Oct 2003 12:00:00 +0200 http://cws.huginonline.com/N/134323/PR/200310/1011642_5.html Novartis International AG <![CDATA[Glivec®: New Study]]> Thu, 9 Oct 2003 08:15:00 +0200 http://cws.huginonline.com/N/134323/PR/200310/919953_5.html Novartis International AG <![CDATA[Novartis partners with Sankyo on gastro-intestinal drug development program]]> Wed, 8 Oct 2003 07:00:00 +0200 http://cws.huginonline.com/N/134323/PR/200310/919780_5.html Novartis International AG <![CDATA[Novartis Enablex(TM) on track for 2004 US launch]]> Fri, 3 Oct 2003 22:45:00 +0200 http://cws.huginonline.com/N/134323/PR/200310/919513_5.html Novartis International AG <![CDATA[FDA requests additional data on arthritis and pain drug, lumiracoxib]]> Tue, 23 Sep 2003 23:16:46 +0200 http://cws.huginonline.com/N/134323/PR/200309/918427_5.html Novartis International AG <![CDATA[Nutritional advance offers support for people with cancer]]> Tue, 23 Sep 2003 00:00:00 +0200 http://cws.huginonline.com/N/134323/PR/200309/1011393_5.html Novartis International AG <![CDATA[Prexige approved in the United Kingdom]]> Tue, 16 Sep 2003 07:30:00 +0200 http://cws.huginonline.com/N/134323/PR/200309/917447_5.html Novartis International AG <![CDATA[New data from Val-HeFT shows Diovan® reduced the incidence of atrial fibrillation by 35% in heart failure patients]]> Tue, 2 Sep 2003 11:00:00 +0200 http://cws.huginonline.com/N/134323/PR/200309/916029_5.html Novartis International AG <![CDATA[Novartis offers direct share purchase plan to investors in Switzerland, Liechtenstein, France and the United Kingdom]]> Tue, 2 Sep 2003 00:00:00 +0200 http://cws.huginonline.com/N/134323/PR/200309/1011630_5.html Novartis International AG <![CDATA[First results of three multicenter open-label clinical trials with StalevoTM show improved symptomatic benefits and enhanced convenience for patients with Parkinson´s disease.]]> Mon, 1 Sep 2003 07:30:00 +0200 http://cws.huginonline.com/N/134323/PR/200309/915818_5.html Novartis International AG <![CDATA[Patients welcome new non-steroid treatment for atopic eczema]]> Fri, 29 Aug 2003 07:30:00 +0200 http://cws.huginonline.com/N/134323/PR/200308/915580_5.html Novartis International AG <![CDATA[Alex Matter to head Novartis Institute for Tropical Diseases (VIRTUAL PRESS KIT)]]> Thu, 28 Aug 2003 12:00:00 +0200 http://cws.huginonline.com/N/134323/PR/200308/1012042_5.html Novartis International AG <![CDATA[NICE recommends Glivec® in England and Wales for first-line treatment of chronic myeloid leukemia patients]]> Thu, 28 Aug 2003 08:00:00 +0200 http://cws.huginonline.com/N/134323/PR/200308/1011370_5.html Novartis International AG <![CDATA[Alex Matter to head Novartis Institute for Tropical Diseases]]> Thu, 28 Aug 2003 07:30:00 +0200 http://cws.huginonline.com/N/134323/PR/200308/915429_5.html Novartis International AG <![CDATA[Novartis launches generic omeprazole in the US]]> Tue, 19 Aug 2003 07:30:08 +0200 http://cws.huginonline.com/N/134323/PR/200308/914254_5.html Novartis International AG <![CDATA[FDA issues approvable letter for updated label for Zometa® to include long-term data for broad range of advanced cancers involving bone]]> Mon, 18 Aug 2003 09:00:00 +0200 http://cws.huginonline.com/N/134323/PR/200308/1010495_5.html Novartis International AG <![CDATA[Novartis Ophthalmics granted exclusive rights for development and commercialization of the first pharmaceutical treatment of myopia from Valley Forge Pharmaceuticals Inc.]]> Fri, 1 Aug 2003 12:00:00 +0200 http://cws.huginonline.com/N/134323/PR/200308/1009186_5.html Novartis International AG <![CDATA[Swissmedic grants approval for the antihypertensive Diovan® to be used in the treatment of heart failure]]> Thu, 24 Jul 2003 07:30:00 +0200 http://cws.huginonline.com/N/134323/PR/200307/911663_5.html Novartis International AG <![CDATA[New Novartis transplant drug Certican® approved in first European market]]> Wed, 23 Jul 2003 07:00:00 +0200 http://cws.huginonline.com/N/134323/PR/200307/911543_5.html Novartis International AG <![CDATA[Novartis delivers strong first-half performance and continues to gain market share]]> Mon, 21 Jul 2003 09:00:00 +0200 http://cws.huginonline.com/N/134323/PR/200307/1010493_5.html Novartis International AG <![CDATA[Glivec® approved in Japan for treatment of life-threatening gastrointestinal cancer]]> Thu, 17 Jul 2003 07:42:51 +0200 http://cws.huginonline.com/N/134323/PR/200307/911074_5.html Novartis International AG <![CDATA[Novartis and GlaxoSmithKline reach settlement in Augmentin ITC lawsuit]]> Thu, 10 Jul 2003 07:30:00 +0200 http://cws.huginonline.com/N/134323/PR/200307/910543_5.html Novartis International AG <![CDATA[Swissmedic approves Leponex® to treat suicidal behaviour in patients with schizophrenia and schizoaffective disorder]]> Thu, 10 Jul 2003 07:27:04 +0200 http://cws.huginonline.com/N/134323/PR/200307/910546_5.html Novartis International AG <![CDATA[Novartis Ophthalmics and Genentech announce development and commercialization agreement for age-related macular degeneration treatment, Lucentis(TM)]]> Wed, 25 Jun 2003 07:15:00 +0200 http://cws.huginonline.com/N/134323/PR/200306/908998_5.html Novartis International AG <![CDATA[FDA approves Xolair®, biotechnology breakthrough for asthma]]> Mon, 23 Jun 2003 08:22:06 +0200 http://cws.huginonline.com/N/134323/PR/200306/908721_5.html Novartis International AG <![CDATA[Results of LIS2T study indicate that Neoral is associated with less diabetes and diarrhoea than tacrolimus in liver transplantation]]> Mon, 23 Jun 2003 08:00:00 +0200 http://cws.huginonline.com/N/134323/PR/200306/1010487_5.html Novartis International AG <![CDATA[New data confirm that Prexige® (lumiracoxib) is effective in relieving symptoms of osteoarthritis]]> Fri, 20 Jun 2003 08:00:00 +0200 http://cws.huginonline.com/N/134323/PR/200306/1011791_5.html Novartis International AG <![CDATA[NICE issues preliminary recommendation for Glivec in England and Wales as first-line drug therapy for patients with chronic myeloid leukemia]]> Wed, 18 Jun 2003 12:00:00 +0200 http://cws.huginonline.com/N/134323/PR/200306/1010098_5.html Novartis International AG <![CDATA[Recipients of the 5th Annual Novartis Award in Diabetes honored today]]> Mon, 16 Jun 2003 12:00:00 +0200 http://cws.huginonline.com/N/134323/PR/200306/1010089_5.html Novartis International AG <![CDATA[FDA approves Stalevo (TM) for treatment of Parkinson's disease]]> Fri, 13 Jun 2003 07:50:05 +0200 http://cws.huginonline.com/N/134323/PR/200306/907565_5.html Novartis International AG <![CDATA[EMEA updates Zometa label to include longer-term efficacy data on prevention of bone complications in advanced cancers]]> Thu, 12 Jun 2003 12:00:00 +0200 http://cws.huginonline.com/N/134323/PR/200306/1010084_5.html Novartis International AG <![CDATA[US International Trade Commission determines legal dispute between GSK and Novartis should go to trial]]> Wed, 11 Jun 2003 12:00:00 +0200 http://cws.huginonline.com/N/134323/PR/200306/1010078_5.html Novartis International AG <![CDATA[Elidel® cream provides fast relief for infants with atopic dermatitis]]> Tue, 10 Jun 2003 12:00:00 +0200 http://cws.huginonline.com/N/134323/PR/200306/1010077_5.html Novartis International AG <![CDATA[Giving the right nutrients before surgery cuts postoperative infections and lowers hospital costs]]> Tue, 3 Jun 2003 12:00:00 +0200 http://cws.huginonline.com/N/134323/PR/200306/1010075_5.html Novartis International AG <![CDATA[Transplanted kidneys from living donors survive longer using immunosuppression with Neoral® compared with tacrolimus]]> Tue, 3 Jun 2003 12:00:00 +0200 http://cws.huginonline.com/N/134323/PR/200306/1010070_5.html Novartis International AG <![CDATA[First and largest statin trial in renal transplant patients demonstrates that Lescol® reduces cardiac death and heart attack]]> Tue, 3 Jun 2003 12:00:00 +0200 http://cws.huginonline.com/N/134323/PR/200306/1010068_5.html Novartis International AG <![CDATA[Early data from 6 600 patients in Glivec® Expanded Access Program consistent with published survival data for Ph+ chronic myeloid leukemia patient]]> Mon, 2 Jun 2003 12:00:00 +0200 http://cws.huginonline.com/N/134323/PR/200306/1010067_5.html Novartis International AG <![CDATA[Study shows longer pre-operative treatment with Femara significantly increases chance of breast-conserving surgery in post-menopausal women with locally advanced breast cancer]]> Mon, 2 Jun 2003 12:00:00 +0200 http://cws.huginonline.com/N/134323/PR/200306/1010066_5.html Novartis International AG <![CDATA[Novartis Medical Nutrition acquires Semper Clinical Nutrition, a leader in medical nutrition in the Nordic region]]> Mon, 2 Jun 2003 12:00:00 +0200 http://cws.huginonline.com/N/134323/PR/200306/1010062_5.html Novartis International AG <![CDATA[Femara® demonstrates early survival advantage over tamoxifen in advanced breast cancer as reported in Journal of Clinical Oncology]]> Thu, 29 May 2003 12:00:00 +0200 http://cws.huginonline.com/N/134323/PR/200305/1010059_5.html Novartis International AG <![CDATA[FDA approves Lescol® and Lescol® XL for secondary prevention of coronary events in patients with coronary heart disease]]> Wed, 28 May 2003 16:30:00 +0200 http://cws.huginonline.com/N/134323/PR/200305/905827_5.html Novartis International AG <![CDATA[Study finds Starlix® significantly improves glycemic control in rosiglitazone patients with type 2 diabetes]]> Wed, 28 May 2003 12:00:00 +0200 http://cws.huginonline.com/N/134323/PR/200305/1010057_5.html Novartis International AG <![CDATA[Novartis: New clinical research data on Glivec®]]> Tue, 27 May 2003 07:30:00 +0200 http://cws.huginonline.com/N/134323/PR/200305/905497_5.html Novartis International AG <![CDATA[Zometa® significantly increased bone mineral density in men receiving hormonal therapy for non-metastatic prostate cancer, study showed]]> Fri, 23 May 2003 12:00:00 +0200 http://cws.huginonline.com/N/134323/PR/200305/1010056_5.html Novartis International AG <![CDATA[New data confirm Zelmac® is effective, safe and well tolerated in treating IBS]]> Wed, 21 May 2003 12:00:00 +0200 http://cws.huginonline.com/N/134323/PR/200305/1010055_5.html Novartis International AG <![CDATA[Return of a traditional name: Novartis Generics rebranded as Sandoz]]> Tue, 20 May 2003 12:00:00 +0200 http://cws.huginonline.com/N/134323/PR/200305/1010054_5.html Novartis International AG <![CDATA[New study shows Zelmac® is effective and well tolerated for chronic constipation]]> Tue, 20 May 2003 12:00:00 +0200 http://cws.huginonline.com/N/134323/PR/200305/1010050_5.html Novartis International AG <![CDATA[FDA advisory committee unanimously recommends approval of Xolair(TM)]]> Fri, 16 May 2003 12:00:00 +0200 http://cws.huginonline.com/N/134323/PR/200305/1010048_5.html Novartis International AG <![CDATA[Novartis closes two strategic acquisitions in pharmaceuticals]]> Fri, 9 May 2003 07:30:00 +0200 http://cws.huginonline.com/N/134323/PR/200305/902926_5.html Novartis International AG <![CDATA[New long-term data show Zometa® slows pain progression and reduces bone complications in advanced prostate cancer]]> Wed, 30 Apr 2003 08:30:00 +0200 http://cws.huginonline.com/N/134323/PR/200304/901262_5.html Novartis International AG <![CDATA[Novartis launches international education program to ensure effective treatment with its fixed dose combination anti-malarial drug product, consisting of artemether and lumefantrine (Coartem®)]]> Fri, 25 Apr 2003 12:00:00 +0200 http://cws.huginonline.com/N/134323/PR/200304/1011952_5.html Novartis International AG <![CDATA[Novartis delivers strong growth in first quarter despite weak economic environment]]> Tue, 15 Apr 2003 12:00:00 +0200 http://cws.huginonline.com/N/134323/PR/200304/1010045_5.html Novartis International AG <![CDATA[New immunosuppressant Certican outperforms azathioprine in lung transplant patients]]> Mon, 14 Apr 2003 07:30:00 +0200 http://cws.huginonline.com/N/134323/PR/200304/899235_5.html Novartis International AG <![CDATA[Novartis and Schering-Plough plan joint development of a fixed inhaled combination of Foradil® and Asmanex® for asthma and COPD]]> Thu, 10 Apr 2003 17:30:00 +0200 http://cws.huginonline.com/N/134323/PR/200304/899065_5.html Novartis International AG <![CDATA[Novartis wins important ruling against GlaxoSmithKline]]> Wed, 9 Apr 2003 07:34:15 +0200 http://cws.huginonline.com/N/134323/PR/200304/898714_5.html Novartis International AG <![CDATA[Elidel® Creme 1% erhält Marktzulassung in der Schweiz]]> Mon, 7 Apr 2003 07:30:00 +0200 http://cws.huginonline.com/N/134323/PR/200304/898214_5.html Novartis International AG <![CDATA[Exelon helps Alzheimer's disease patients to maintain greater independence]]> Thu, 3 Apr 2003 08:30:00 +0200 http://cws.huginonline.com/N/134323/PR/200304/897775_5.html Novartis International AG <![CDATA[Baseline data from VALIANT identifies risk factors that compromise survival after heart attack]]> Tue, 1 Apr 2003 12:00:00 +0200 http://cws.huginonline.com/N/134323/PR/200304/1009417_5.html Novartis International AG <![CDATA[Lescol®: New Findings from LIPS presented at ACC]]> Mon, 31 Mar 2003 10:30:00 +0200 http://cws.huginonline.com/N/134323/PR/200303/897358_5.html Novartis International AG <![CDATA[Novartis signs collaboration agreement with Regeneron for rheumatoid arthritis compounds]]> Fri, 28 Mar 2003 14:54:27 +0100 http://cws.huginonline.com/N/134323/PR/200303/897295_5.html Novartis International AG <![CDATA[MEDIA RELEASE]]> Wed, 26 Mar 2003 07:42:32 +0100 http://cws.huginonline.com/N/134323/PR/200303/896847_5.html Novartis International AG <![CDATA[MEDIA RELEASE]]> Tue, 18 Mar 2003 08:00:53 +0100 http://cws.huginonline.com/N/134323/PR/200303/895852_5.html Novartis International AG <![CDATA[Data Show Novartis drug Zometa® offers important advance as first bisphosphonate to significantly reduce bone complications common in kidney cancer]]> Fri, 14 Mar 2003 12:00:00 +0100 http://cws.huginonline.com/N/134323/PR/200303/1009386_5.html Novartis International AG <![CDATA[Data prove Glivec® is superior treatment for patients newly diagnosed with chronic myeloid leukemia]]> Thu, 13 Mar 2003 12:00:00 +0100 http://cws.huginonline.com/N/134323/PR/200303/1009383_5.html Novartis International AG <![CDATA[New survey indicates need for increased awareness and formal diagnosis of Irritable Bowel Syndrome]]> Wed, 12 Mar 2003 12:00:00 +0100 http://cws.huginonline.com/N/134323/PR/200303/1009380_5.html Novartis International AG <![CDATA[Novartis shareholders approve dividend increase of 6% based on good performance in 2002]]> Tue, 4 Mar 2003 12:00:00 +0100 http://cws.huginonline.com/N/134323/PR/200303/1009370_5.html Novartis International AG <![CDATA[Glivec® approved in European Union for first-line treatment of adults and children with chronic myeloid leukemia]]> Sat, 1 Mar 2003 12:00:00 +0100 http://cws.huginonline.com/N/134323/PR/200303/1009183_5.html Novartis International AG <![CDATA[Novartis Media Release - Zometa receives positive CPMP opinion for label update]]> Tue, 25 Feb 2003 07:45:00 +0100 http://cws.huginonline.com/N/134323/PR/200302/893045_5.html Novartis International AG <![CDATA[Elidel cream 1% shown effective treatment with proven safety profile for infant eczema, study reports]]> Mon, 24 Feb 2003 12:00:00 +0100 http://cws.huginonline.com/N/134323/PR/200302/1009365_5.html Novartis International AG <![CDATA[New study offers hope for patients with acromegaly, a rare, life-threatening hormonal disorder]]> Wed, 19 Feb 2003 12:00:00 +0100 http://cws.huginonline.com/N/134323/PR/200302/1009363_5.html Novartis International AG <![CDATA[Federal Circuit Court Upholds Lower Court Decision Preventing Sale of PureVision Contact Lenses in the U.S.]]> Wed, 12 Feb 2003 12:00:00 +0100 http://cws.huginonline.com/N/134323/PR/200302/1009344_5.html Novartis International AG <![CDATA[Media Release]]> Wed, 12 Feb 2003 08:53:25 +0100 http://cws.huginonline.com/N/134323/PR/200302/891266_5.html Novartis International AG <![CDATA[Novartis files in Japan for approval of Glivec® for treatment of gastrointestinal cancer]]> Thu, 30 Jan 2003 07:30:00 +0100 http://cws.huginonline.com/N/134323/PR/200301/889933_5.html Novartis International AG <![CDATA[Novartis European Young Investigator Award in Chemistry 2002 to Bernhard Breit and Thomas Carell]]> Mon, 27 Jan 2003 12:00:00 +0100 http://cws.huginonline.com/N/134323/PR/200301/1009339_5.html Novartis International AG <![CDATA[Novartis Consumer Health launches over-the-counter Loratadine]]> Sat, 25 Jan 2003 12:00:00 +0100 http://cws.huginonline.com/N/134323/PR/200301/1009336_5.html Novartis International AG <![CDATA[Novartis Financial Results 2002 - ENGLISH VIRTUAL PRESS KIT]]> Thu, 23 Jan 2003 12:00:00 +0100 http://cws.huginonline.com/N/134323/PR/200301/1011990_5.html Novartis International AG <![CDATA[Novartis meets full-year double-digit sales growth objective with strong operating performance in 2002]]> Thu, 23 Jan 2003 12:00:00 +0100 http://cws.huginonline.com/N/134323/PR/200301/1009328_5.html Novartis International AG <![CDATA[Novartis to unite its generics businesses under one single global brand: SANDOZ]]> Tue, 21 Jan 2003 12:00:00 +0100 http://cws.huginonline.com/N/134323/PR/200301/1009221_5.html Novartis International AG <![CDATA[License agreement for new multi dose dry powder inhaler Airmax(TM) signed]]> Fri, 17 Jan 2003 12:00:00 +0100 http://cws.huginonline.com/N/134323/PR/200301/1009199_5.html Novartis International AG <![CDATA[VIRTUAL PRESS KIT - Novartis Venture Fund reports substantial increase in its venture capital to around CHF 300 million]]> Thu, 16 Jan 2003 12:00:00 +0100 http://cws.huginonline.com/N/134323/PR/200301/1011943_5.html Novartis International AG <![CDATA[Steven Kelmar appointed Head of Public Affairs and Corporate Communications at Novartis]]> Thu, 16 Jan 2003 12:00:00 +0100 http://cws.huginonline.com/N/134323/PR/200301/1009193_5.html Novartis International AG